US20170367709A1 - Implant detachment with thermal activation - Google Patents
Implant detachment with thermal activation Download PDFInfo
- Publication number
- US20170367709A1 US20170367709A1 US15/610,713 US201715610713A US2017367709A1 US 20170367709 A1 US20170367709 A1 US 20170367709A1 US 201715610713 A US201715610713 A US 201715610713A US 2017367709 A1 US2017367709 A1 US 2017367709A1
- Authority
- US
- United States
- Prior art keywords
- implant
- sectional dimension
- coil
- delivery system
- pusher device
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000007943 implant Substances 0.000 title claims abstract description 148
- 238000007725 thermal activation Methods 0.000 title 1
- 230000007704 transition Effects 0.000 claims abstract description 34
- 238000010438 heat treatment Methods 0.000 claims description 33
- 238000000034 method Methods 0.000 claims description 31
- 239000012781 shape memory material Substances 0.000 claims description 4
- 230000000087 stabilizing effect Effects 0.000 claims description 2
- 206010002329 Aneurysm Diseases 0.000 abstract description 14
- 230000007556 vascular defect Effects 0.000 abstract 1
- 238000005516 engineering process Methods 0.000 description 46
- 238000012546 transfer Methods 0.000 description 6
- 230000008901 benefit Effects 0.000 description 5
- 230000005540 biological transmission Effects 0.000 description 5
- 239000010410 layer Substances 0.000 description 5
- 229910001000 nickel titanium Inorganic materials 0.000 description 5
- SXKZZFLSYPUIAN-UHFFFAOYSA-N [Cu].[Zn].[Au] Chemical compound [Cu].[Zn].[Au] SXKZZFLSYPUIAN-UHFFFAOYSA-N 0.000 description 4
- 230000036760 body temperature Effects 0.000 description 4
- -1 copper-aluminum-nickel Chemical compound 0.000 description 4
- 229920001903 high density polyethylene Polymers 0.000 description 4
- 239000004700 high-density polyethylene Substances 0.000 description 4
- 230000033001 locomotion Effects 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 239000005020 polyethylene terephthalate Substances 0.000 description 4
- 229920000139 polyethylene terephthalate Polymers 0.000 description 4
- 238000004804 winding Methods 0.000 description 4
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 3
- PDYXSJSAMVACOH-UHFFFAOYSA-N [Cu].[Zn].[Sn] Chemical compound [Cu].[Zn].[Sn] PDYXSJSAMVACOH-UHFFFAOYSA-N 0.000 description 2
- FFCYCDBKNAJFNJ-UHFFFAOYSA-N [Ti].[Fe].[Co].[Ni] Chemical compound [Ti].[Fe].[Co].[Ni] FFCYCDBKNAJFNJ-UHFFFAOYSA-N 0.000 description 2
- HZEWFHLRYVTOIW-UHFFFAOYSA-N [Ti].[Ni] Chemical compound [Ti].[Ni] HZEWFHLRYVTOIW-UHFFFAOYSA-N 0.000 description 2
- BUUNILCKFRLOQJ-UHFFFAOYSA-N [Ti].[V].[Ni] Chemical compound [Ti].[V].[Ni] BUUNILCKFRLOQJ-UHFFFAOYSA-N 0.000 description 2
- AEKXYPDMHSMNRN-UHFFFAOYSA-N [Xe].[Zn].[Cu] Chemical compound [Xe].[Zn].[Cu] AEKXYPDMHSMNRN-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 229910001566 austenite Inorganic materials 0.000 description 2
- 229910052790 beryllium Inorganic materials 0.000 description 2
- WJCRZORJJRCRAW-UHFFFAOYSA-N cadmium gold Chemical compound [Cd].[Au] WJCRZORJJRCRAW-UHFFFAOYSA-N 0.000 description 2
- NSAODVHAXBZWGW-UHFFFAOYSA-N cadmium silver Chemical compound [Ag].[Cd] NSAODVHAXBZWGW-UHFFFAOYSA-N 0.000 description 2
- KUNSUQLRTQLHQQ-UHFFFAOYSA-N copper tin Chemical compound [Cu].[Sn] KUNSUQLRTQLHQQ-UHFFFAOYSA-N 0.000 description 2
- TVZPLCNGKSPOJA-UHFFFAOYSA-N copper zinc Chemical compound [Cu].[Zn] TVZPLCNGKSPOJA-UHFFFAOYSA-N 0.000 description 2
- 230000003073 embolic effect Effects 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- DALUDRGQOYMVLD-UHFFFAOYSA-N iron manganese Chemical compound [Mn].[Fe] DALUDRGQOYMVLD-UHFFFAOYSA-N 0.000 description 2
- OBACEDMBGYVZMP-UHFFFAOYSA-N iron platinum Chemical compound [Fe].[Fe].[Pt] OBACEDMBGYVZMP-UHFFFAOYSA-N 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229920002635 polyurethane Polymers 0.000 description 2
- 239000004814 polyurethane Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 229910001285 shape-memory alloy Inorganic materials 0.000 description 2
- 229920000431 shape-memory polymer Polymers 0.000 description 2
- 229910052716 thallium Inorganic materials 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- 210000003484 anatomy Anatomy 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000012282 endovascular technique Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000010297 mechanical methods and process Methods 0.000 description 1
- 210000003101 oviduct Anatomy 0.000 description 1
- 239000013618 particulate matter Substances 0.000 description 1
- 239000012858 resilient material Substances 0.000 description 1
- 230000006903 response to temperature Effects 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 238000013151 thrombectomy Methods 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
- A61B17/12109—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
- A61B17/12113—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel within an aneurysm
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12027—Type of occlusion
- A61B17/12031—Type of occlusion complete occlusion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M29/00—Dilators with or without means for introducing media, e.g. remedies
- A61M29/02—Dilators made of swellable material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/1214—Coils or wires
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/12168—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure
- A61B17/12172—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure having a pre-set deployed three-dimensional shape
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
- A61B2017/00632—Occluding a cavity, i.e. closing a blind opening
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B2017/00831—Material properties
- A61B2017/00862—Material properties elastic or resilient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B2017/00831—Material properties
- A61B2017/00867—Material properties shape memory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B2017/00831—Material properties
- A61B2017/00955—Material properties thermoplastic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B2017/1205—Introduction devices
- A61B2017/12054—Details concerning the detachment of the occluding device from the introduction device
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B2017/1205—Introduction devices
- A61B2017/12054—Details concerning the detachment of the occluding device from the introduction device
- A61B2017/12068—Details concerning the detachment of the occluding device from the introduction device detachable by heat
- A61B2017/12077—Joint changing shape upon application of heat, e.g. bi-metal or reversible thermal memory
Definitions
- the subject technology relates to the delivery of implantable medical devices and systems for delivering implantable medical devices.
- vascular aneurysms can be occluded with an implant that is introduced with a pusher member through a catheter. Once advanced to the treatment site, the implant is inserted into the aneurysm cavity to occlude the aneurysm and then detached from the pusher member.
- Detachment of an implant from the pusher member can be problematic. It is essential that the implant form as small a profile as possible to be guided through the fine bore of a catheter and it must be configured to bring about a reliable severance of the implant from the pusher member. Absent a reliable severance of the implant, withdrawal of the pusher member and catheter may cause unintended removal of the implant from the aneurysm or vessel to be occluded, and thus injure and/or rupture of the wall of the aneurysm or vessel.
- a thermally activated detachment mechanism can be employed for controllably releasing an implantable medical device from a delivery connection assembly in a reliable, rapid, and accurate manner.
- Thermally activated detachment mechanisms can have advantages compared to electrolytic detachment systems.
- severance of implantable medical devices can involve engagement and disengagement by a delivery connection assembly that minimizes a protruding aspect of the medical devices at an engagement region thereof.
- the delivery connection assembly can be designed to engage the medical device such that, after disengagement, the mechanisms for engagement are removed with the delivery connection assembly.
- Such an arrangement can facilitate rapid severance and leave a medical device without an end that protrudes as far as would an implant's connection to an electrolytic detachment junction after detachment.
- electrolytic detachment of an implant can leave a portion of the delivery wire protruding from the implant after detachment, presenting a risk of harm to the surrounding anatomy. Additionally, electrolytic detachment can leave behind debris, such as small particulate matter, that can interfere with MRI imaging during a procedure.
- Thermally activated detachment mechanisms also can have advantages compared to mechanical detachment systems. For example, while some mechanical methods for the severance of implants from delivery systems are reliable, mechanical energy must be transmitted (e.g., by rotation of the delivery wire), which may cause the implant to be dislodged out of the correct position. A thermally activated detachment system can avoid the need for transmission of mechanical energy.
- a delivery system comprising:
- each of the arms comprises a longitudinal section extending from the junction to the distal section.
- Clause 3 The delivery system of any one of clauses 1-2, wherein the distal sections extend radially outwardly.
- Clause 4 The delivery system of any one of clauses 1-3, wherein the distal sections define a maximum outer cross-sectional dimension of a distal region of the pusher device.
- Clause 6 The delivery system of any one of clauses 1-5, further comprising a heating element thermally connected to the pusher device.
- Clause 7 The delivery system of any one of clauses 1-6, further comprising an electrical circuit thermally connected to the pusher device.
- Clause 8 The delivery system of any one of clauses 1-7, wherein the proximal portion of the implant is a circumferentially continuous hub.
- Clause 9 The delivery system of any one of clauses 1-8, wherein the proximal portion of the implant is a helical coil.
- a method of delivering an implant comprising:
- Clause 11 The method of clause 10, wherein the releasing comprises operating a heating element thermally connected to the pusher device.
- Clause 12 The method of any one of clauses 10-11, wherein the releasing comprises conducting an electrical current through the pusher device.
- Clause 13 The method of any one of clauses 10-12, wherein the releasing comprises retracting the distal sections of the arms proximally from the cavity through the port.
- Clause 14 The method of clause 13, wherein the releasing further comprises, while retracting the distal sections of the arms, stabilizing the implant with a catheter housing at least a portion of the pusher device.
- Clause 15 The method of any one of clauses 10-14, wherein the releasing comprises articulating the arms with respect to the junction.
- a delivery system comprising:
- Clause 17 The delivery system of clause 16, wherein at least a portion of the coil extends distally of an entire length of the proximal portion.
- Clause 18 The delivery system of any one of clauses 16-17, wherein the coil is of a shape memory material.
- Clause 19 The delivery system of any one of clauses 16-18, further comprising a heating element thermally connected to the pusher device.
- Clause 20 The delivery system of any one of clauses 16-19, further comprising an electrical circuit thermally connected to the pusher device.
- Clause 21 The delivery system of any one of clauses 16-20, wherein the proximal portion of the implant is a circumferentially continuous hub.
- a method of delivering an implant comprising:
- Clause 23 The method of clause 22, wherein the releasing comprises operating a heating element thermally connected to the pusher device.
- Clause 24 The method of any one of clauses 22-23, wherein the releasing comprises conducting an electrical current through the coil.
- Clause 25 The method of any one of clauses 22-24, wherein the releasing comprises retracting the coil proximally from the implant.
- FIG. 1A shows a plan view of a delivery system in accordance with some embodiments of the subject technology.
- FIG. 1B shows an enlarged view of a distal portion of FIG. 1A , in accordance with one or more embodiments of the present disclosure.
- FIG. 2A shows a perspective side view of a braid ball implant, in accordance with one or more embodiments of the subject technology.
- FIG. 2B shows a sectional view of the braid ball implant of FIG. 2B , in accordance with one or more embodiments of the subject technology.
- FIG. 3 shows in partial cross-section a portion of the delivery system and the braid ball implant of FIGS. 2A-2B , in accordance with some embodiments of the subject technology.
- FIG. 4 shows a partial sectional view of a distal end of the delivery system of FIG. 1A connected to a proximal portion of the braid ball implant of FIGS. 2A-2B , in accordance with one or more embodiments of the subject technology.
- FIG. 5A shows a sectional view of the distal end of the delivery system and proximal portion of the braid ball implant of FIG. 4 , in accordance with one or more embodiments of the present disclosure.
- FIG. 5B shows a sectional view of the distal end of the delivery system and proximal portion of the braid ball implant of FIG. 4 , in accordance with one or more embodiments of the present disclosure.
- FIG. 5C shows a sectional view of the distal end of the delivery system and proximal portion of the braid ball implant of FIG. 4 , in accordance with one or more embodiments of the present disclosure.
- FIG. 6 shows a partial sectional view of a distal end of a delivery system and a proximal portion of a coil implant, in accordance with one or more embodiments of the subject technology.
- FIG. 7 shows a view of a delivery system in partial cross-section and the braid ball implant of FIGS. 2A-2B , in accordance with some embodiments of the subject technology.
- FIG. 8A shows a side view of a distal end of a delivery system and a proximal portion of an implant, in accordance with one or more embodiments of the subject technology.
- FIG. 8B shows a partial sectional view of the distal end of the delivery system and proximal portion of the implant of FIG. 8A , in accordance with one or more embodiments of the subject technology.
- FIG. 9A shows a sectional view of the distal end of the delivery system and the proximal portion of the implant of FIG. 8A , in accordance with one or more embodiments of the present disclosure.
- FIG. 9B shows a sectional view of the distal end of the delivery system and the proximal portion of the implant of FIG. 8A , in accordance with one or more embodiments of the present disclosure.
- An implantable medical device e.g., a vascular implant
- a delivery system 10 such as, for example, the one shown in FIGS. 1A-1B .
- the delivery system 10 can include an actuator 20 , a positioner 40 coupled with the actuator 20 , and a delivery connection assembly (not shown) extending from the actuator 20 and within the positioner 40 .
- a portion of a delivery system 10 may engage a complementary portion of an implant 95 in order to control the delivery and detachment of the implant 95 at the desired location.
- a power supply 70 can be coupled to a proximal portion of the positioner 40 , for example at the actuator 20 .
- a current can flow from the power supply 70 along a first lead 72 to a location near the implant 95 and along a second lead 74 from the location near the implant 95 to the power supply 70 .
- the power supply 70 may be a direct current power supply, an alternating current power supply, or a power supply switchable between a direct current and an alternating current.
- a positive terminal of the power supply 70 for example as shown in FIG. 1A , may be coupled to the first lead 72
- a negative terminal of the power supply 70 may be coupled to the second lead 74 .
- the power supply 70 may provide a current through the delivery system 10 to initiate a heating process during use of the delivery system 10 to release the implant 95 , as discussed further herein.
- the power supply 70 can include an electrical generator configured to output an electrical current that is sufficient to actuate the delivery system 10 to release the implant 95 .
- the power supply 70 can include a suitable controller that can be used to control various parameters of the energy output by the generator, such as intensity, amplitude, duration, frequency, duty cycle, and polarity.
- an implant 95 delivered by the delivery system 10 can be or include a braid ball 92 . While the implant 95 is shown or described in several embodiments as comprising a braid ball 92 , any implant or device that is compatible with the subject technology may be used in lieu of or in conjunction with the example implant 95 disclosed herein, in accordance with the embodiments described herein. Suitable implants and devices include, but are not limited to, stents, filters, thrombectomy devices, atherectomy devices, flow restoration devices, embolic coils, spherical devices, embolic protection devices, or other well-known treatment devices.
- the braid ball 92 can be formed from tubular braid stock including a resilient material, such as nitinol, that defines an open volume in an uncompressed/unconstrained state.
- the size of the implant can be selected to fill an aneurysm when expanded therein.
- the implant 95 can include a hub 50 and layers 26 , 28 .
- the hub can be located at a proximal portion 53 of the implant.
- the hub 50 can be fixedly attached to the remainder of the implant 95 .
- the hub 50 can grasp braided filaments of the layers 26 , 28 of the implant 95 .
- the implant 95 can include the layers 26 , 28 at least where impacted by flow at a neck of the aneurysm.
- the hub 50 can be fixedly attached to the remainder of the implant 95 .
- the hub 50 can grasp braided filaments of the layers 26 , 28 of the implant 95 .
- a port 54 can be provided within the hub 50 .
- the port 54 can define a port inner cross-sectional dimension 58 .
- the port inner cross-sectional dimension 58 can be a minimum or maximum inner cross-sectional dimension within a region of the proximal portion 53 .
- a region distal to the hub 50 can include a cavity 96 that defines an inner cross-sectional dimension 98 that is greater than the port inner cross-sectional dimension 58 .
- the hub 50 can further define a hub outer cross-sectional dimension 59 .
- the hub outer cross-sectional dimension 59 can be a minimum or maximum outer cross-sectional dimension within a region of the proximal portion 53 .
- a region distal to the hub 50 can define an outer cross-sectional dimension 57 that is smaller than the hub outer cross-sectional dimension 59 .
- the port 54 or an outer surface of the hub 50 can accept the implant 95 . Delivery system construction and further optional details of the implant 95 are provided below.
- FIG. 3 shows the braid ball 92 attached to a distal end 22 of the delivery system 10 , and positioned within an aneurysm 16 .
- the delivery system 10 extends proximally from the implant 95 to a location outside of the body where the delivery system can be manipulated by a user. As illustrated in FIG.
- the delivery system 10 can comprise a microcatheter 14 and a delivery connection assembly that includes the positioner 40 .
- the microcatheter 14 is advanced until its distal end is in the vicinity of a target site, such as the aneurysm 16 , for example as shown in FIG. 3 .
- the positioner 40 is advanced within the microcatheter 14 to access the target site.
- the positioner 40 can be advanced out of the microcatheter 14 and directed to the target site.
- the implant 95 can be advanced with the positioner 40 until the implant 95 is positioned at the target site.
- the delivery system 10 and the microcatheter 14 can have lengths sufficient to extend from outside the patient's body to a target location in the brain. For example, each of them can be at least 125 cm long, and more particularly may be between about 125 cm and about 175 cm long, with the delivery system 10 being longer than the microcatheter 14 . Typically the microcatheter 14 is about 155 cm long.
- Commercially available microcatheters which may be suitable for use as delivery catheters include the REBARTM Reinforced Micro Catheter, which is available from Medtronic, Inc. and the MARKSMANTM Catheter, which is available from Medtronic, Inc.
- the implant 95 can be inserted within the aneurysm 16 and expanded to a fully deployed state, for example as illustrated in FIG. 3 .
- the position of the implant 95 can be affected and/or modified by corresponding motion of the delivery system 10 .
- a radiopaque marker (e.g., the hub 50 ) of the implant 95 can be utilized to track and confirm delivery of the implant 95 to the target location.
- the implant 95 is supported during delivery by a delivery connection assembly 12 , from which the implant 95 can also be detached.
- the delivery connection assembly 12 can include the positioner 40 , a pusher device 78 and a heating element 76 .
- the pusher device 78 can include one or more arms 82 that engage the implant 95 .
- the heating element 76 can controllably provide heat to the pusher device 78 to actuate the arms until the arms 82 released the implant 95 .
- the pusher device 78 can include one or more arms 82 extending distally from a junction 80 of the pusher device 78 and through the port 54 .
- One or more of the arms 82 can include a distal section 84 that can be positioned distal to at least a portion of the port 54 and/or within a cavity 96 of the implant 95 .
- the arms 82 can extend longitudinally from the junction 80 , and the distal sections 84 can extend radially outwardly from the arms 82 .
- the distal sections 84 can define a maximum outer cross-sectional dimension 86 that is greater than the port inner cross-sectional dimension 58 . Accordingly, passage of the distal sections 84 proximally through the port 54 is resisted until the distal sections 84 are transitioned to a different configuration.
- the arms 82 are configured to flex, bend, pivot, or articulate with respect to the junction 80 in response to temperature changes. Such action can be achieved based on a programmed characteristic of the arms 82 .
- the arms 82 can transition to a second configuration, such as an austenite state in a shape memory alloy, in which the arms 82 in a relaxed state can disengage from the implant 95 , as will be more fully described herein.
- the transition temperature at which the arms 82 begin to revert to the second configuration can be selected at the typical human body temperature (i.e., about 36.7° C. or 98° F.) or another temperature.
- the transition temperature can be selected above the typical human body temperature, and the transition temperature can be achieved in the arms 82 by an application of heat other than from the body.
- Exemplifying materials for use in the composition of the junction 80 and/or the arms 82 can include nickel-titanium (nitinol), copper-tin, copper-zinc, copper-zinc-tin, copper-zinc-xenon, copper-aluminum-nickel, copper-gold-zinc, gold-cadmium, gold-copper-zinc, iron-beryllium, iron-platinum, indium-thallium, iron-manganese, iron-nickel-titanium-cobalt, nickel-titanium-vanadium, silver-cadmium, and combinations thereof.
- Exemplifying materials can further include a shape memory polymer, such as polyurethane, polyethylene terephthalate (PET), or high density polyethylene (HDPE).
- a heating element 76 can be provided in thermal connection with the junction 80 and the arms 82 .
- the heating element 76 can be connected to the power supply 70 via the first and second leads 72 , 74 to direct a current through the heating element 76 .
- the leads 72 , 74 can extend alongside the pusher device 78 within a lumen of the positioner 40 and proximally from the heating element 76 to outside the patient's body.
- At least a portion of the heating element 76 can provide an electrical circuit with adequate resistance to generate heat while electrical current is applied.
- the heating element 76 can include a number of coil windings about a portion of the pusher device 78 , for example as illustrated in FIG. 4 .
- the heating element 76 can contact or be in close proximity to one or more of the junction 80 and the arms 82 .
- the heating element 76 can be adjacent to or overlap with one or more of the junction 80 and the arms 82 .
- Heat generated by the heating element 76 can be conducted to achieve an increase in temperature along one or more portions of the pusher device 78 .
- the heating element 76 can include other heat transmission elements such as a heat pipe that transfers heat via convention of heat transfer media therethrough or a fiber optic cable that transfers heat via transmission of light.
- the arms 82 and/or the junction 80 may serve as a heating element by directing an electrical current therethrough.
- FIGS. 5A-5C illustrate various stages of an exemplifying method according to one or more embodiments of the subject technology.
- FIG. 5A illustrates the delivery connection assembly 12 and implant 95 of FIG. 4 with the hub 50 of the implant held between the pusher device 78 and the positioner 40 .
- FIG. 5B illustrates a stage of detachment in progress.
- FIG. 5C illustrates the implant 95 detached from the delivery system 10 .
- the implant 95 can be positioned with the positioner 40 and the pusher device 78 . Distally directed forces can be transmitted from the positioner 40 to the hub 50 of the implant 95 . Additionally, proximally directed forces can be transmitted from the pusher device 78 to the hub 50 of the implant 95 .
- a transition of the arms 82 can be achieved to facilitate removal of the arms 82 from engagement with the implant 95 .
- the transition can be achieved as described herein, for example by applying heat to the arms 82 and/or the junction 80 .
- the distal sections 84 can transition (e.g., move inwardly as illustrated in FIGS. 5A and 5B ) from the maximum outer cross-sectional dimension 86 to a second maximum outer cross-sectional dimension 88 that is smaller than the port inner cross-sectional dimension 58 .
- the transition of the arms 82 can allow the arms 82 to completely disengage from the implant 95 .
- the arms 82 can move proximally through the port 54 such that the distal sections 84 are entirely proximal of the implant 95 .
- the positioner 40 can stabilize the implant 95 , for example by applying a distally directed force while the positioner 40 contacts the hub 50 .
- the pusher device 78 Upon full disengagement by the pusher device 78 , the pusher device 78 , the positioner 40 , the microcatheter 14 (if employed), and/or a guide catheter 13 (if employed) can be retracted away from the target implant site and out of the patient, leaving the implant 95 at the target implant site.
- FIGS. 4-5C illustrate an implant 95 comprising a braid ball 92
- the delivery system 10 can be used with a coil implant 90 , for example as illustrated in part in FIG. 6 , according to one or more embodiments of the subject technology. Therefore, the positioner 40 and other elements and components of the delivery system 10 are neither illustrated in FIG. 6 nor described again in detail with reference to FIG. 6 , as these components can be readily understood from the other disclosure of them herein.
- the pusher device 78 can be configured to engage a coil implant 90 .
- the coil implant 90 can include a proximal portion 102 and a distal portion 104 .
- the proximal portion 102 can be smaller than the distal portion 104 and reside at least partially within a cavity 196 of the distal portion 104 , such that the proximal portion 102 and the distal portion 104 at least partially overlap.
- the proximal portion 102 and the distal portion 104 can form separate portions of a continuous helical coil.
- the proximal portion 102 and the distal portion 104 can be separate structures that are joined together by an intervening structure.
- proximal portion 102 and the distal portion 104 can also form another circumferentially continuous structure, such as a cylindrical tube as an alternative to a helical coil or in combination with a helical coil.
- the proximal portion 102 can be disposed at the proximal end of the distal portion 104 and can further define a port 154 .
- the port 154 can extend completely through the proximal portion 102 .
- the port 154 can be large enough to receive the arms 82 of the pusher device 78 .
- the port 154 can define a port inner cross-sectional dimension 158 .
- the port inner cross-sectional dimension 158 can be a minimum or maximum inner cross-sectional dimension within a region of the proximal portion 102 .
- a region distal to the proximal portion 102 can include a cavity 196 that defines an inner cross-sectional dimension 198 that is greater than the port inner cross-sectional dimension 158 .
- one or more of the distal sections 84 can be positioned distal to at least a portion of the port 154 and/or within the cavity 196 of the coil implant 90 .
- the distal sections 84 can define a maximum outer cross-sectional dimension 86 that is greater than the port inner cross-sectional dimension 158 .
- the distal sections 84 can extend into one or more gaps between windings of the distal portion 104 of the coil implant 90 .
- the distal sections 84 can define a maximum outer cross-sectional dimension 86 that is greater than the inner cross-sectional dimension 198 of the distal portion 104 . Accordingly, passage of the distal sections 84 proximally through the port 154 is resisted until the distal sections 84 are transitioned to a different configuration.
- FIGS. 3-6 illustrate the delivery system 10 engaging the implant 95 within a cavity thereof
- a delivery system 110 can be used to engage an outer portion of the implant 95 , for example as illustrated in part in FIG. 7 , according to one or more embodiments of the subject technology.
- the implant 95 can be attached to a distal end 121 of the delivery system 110 , and positioned within an aneurysm 16 .
- the delivery system 110 can comprise a microcatheter 14 and a delivery connection assembly that includes the positioner 140 .
- the microcatheter 14 is advanced until its distal end is in the vicinity of a target site, such as the aneurysm 16 , for example as shown in FIG. 7 .
- the positioner 140 is advanced within the catheter 14 to access the target site.
- FIG. 8A shows an enlarged view of the distal end 121 of the delivery system 110 and a proximal portion of the implant 95 of FIG. 7 .
- FIG. 8B shows a partial sectional view of the distal end 121 of the delivery system 110 and the proximal portion of the implant 95 shown in FIG. 8 .
- FIGS. 8A and 8B show the implant 95 supported during delivery by a delivery connection assembly 122 , from which the implant 95 can also be detached.
- the delivery connection assembly 122 can include fewer components than the delivery connection assembly 12 , described above.
- the delivery connection assembly 122 can include the positioner 140 and one or more coils 182 extending helically and distally from a pusher section 180 of the positioner 140 .
- the coil 182 can be positioned to extend about an outer periphery of a portion of the implant 95 .
- the coil 182 can wrap up around and engage the hub 50 of the implant 95 .
- the coil 182 can extend proximal to the hub 50 , along a length of the hub 50 , and/or distal to the hub 50 .
- the coil 182 can extend to regions on one or both sides of the hub 50 .
- a distalmost region of the coil 182 can engage a distal end of the hub 50 .
- a proximalmost region of the coil 182 can engage a proximal end of the hub 50 .
- a separate structure of the delivery connection assembly 122 e.g., a stop, can engage a proximal end of the hub 50 .
- the coil 182 can be affixed to the pusher section 180 of the positioner 140 , such that movement of the pusher section 180 substantially transmit forces to the coil 182 and the implant 95 .
- the coil 182 can be biased to form an inner cross-sectional dimension 188 that is smaller than the hub outer cross-sectional dimension 59 .
- the bias of the coil 182 can refer to the tendency of the coil 182 , in a relaxed configuration, to naturally move to a shape in which it forms the inner cross-sectional dimension 188 . Despite this bias, the coil 182 may be prevented from completely achieving the shape of the relaxed configuration and instead engage the hub 50 .
- At least a portion of the coil 182 may have an inner cross-sectional dimension 188 that is equal to the hub outer cross-sectional dimension 59 of the hub 50 .
- the bias can provide a force of engagement with the hub 50 . Accordingly, movement of the hub 50 is limited or resisted until the coil 182 is transitioned to a different configuration.
- the coil 182 is configured to flex, bend, unwind, and/or radially expand. Such action can be achieved based on a programmed characteristic of the coil 182 .
- the coil 182 can transition to a second configuration, such as an austenite state in a shape memory alloy, in which the coil 182 in a relaxed state can disengage from the implant 95 , as will be more fully described herein.
- the transition temperature at which the coil 182 begins to revert to the second configuration can be selected at the typical human body temperature (i.e., about 36.7° C. or 98° F.) or another temperature.
- the transition temperature can be selected above the typical human body temperature, and the transition temperature can be achieved in the coil 182 by an application of heat other than from the patient's body.
- Exemplifying materials for use in the composition of the coil 182 can include nickel-titanium (nitinol), copper-tin, copper-zinc, copper-zinc-tin, copper-zinc-xenon, copper-aluminum-nickel, copper-gold-zinc, gold-cadmium, gold-copper-zinc, iron-beryllium, iron-platinum, indium-thallium, iron-manganese, iron-nickel-titanium-cobalt, nickel-titanium-vanadium, silver-cadmium, and combinations thereof.
- Exemplifying materials can further include a shape memory polymer, such as polyurethane, polyethylene terephthalate (PET), or high density polyethylene (HDPE).
- a heating element 176 can be provided in thermal connection with the pusher section 180 and the coil 182 .
- the heating element 176 can be connected to the power supply 70 via the first and second leads 172 , 174 to direct a current through the heating element 176 .
- the leads 172 , 174 can extend within a lumen of the positioner 140 and proximally from the heating element 176 to outside the patient's body.
- At least a portion of the heating element 176 can provide an electrical circuit with adequate resistance to generate heat while electrical current is applied.
- the heating element 176 can include a number of coil windings within a portion of the positioner 140 , for example as illustrated in FIG. 8B .
- the heating element 176 can contact or be in close proximity to one or more of the pusher section 180 and the coil 182 .
- the heating element 176 can be adjacent to or overlap with one or more of the pusher section 180 and the coil 182 . Heat generated by the heating element 176 can be conducted to achieve an increase in temperature along one or more portions of the positioner 140 .
- the heating element 176 can include other heat transmission elements such as a heat pipe that transfers heat via convention of heat transfer media therethrough or a fiber optic cable that transfers heat via transmission of light.
- the coil 182 and/or the pusher section 180 may serve as a heating element by directing an electrical current therethrough.
- the coil 182 can be a single filament helical winding, as shown in FIGS. 8A and 8B , other shapes for engaging the implant 95 are contemplated.
- the coil 182 can include multiple filaments that are the same or different sizes.
- the filaments can be wound in the same direction or counter wound.
- the filaments can be provided in a single layer or in multiple concentric layers.
- other shapes can be used to engage the implant 95 , such as a circumferentially continuous structure, such as a cylindrical tube.
- FIGS. 9A and 9B illustrate various stages of an exemplifying method according to one or more embodiments of the subject technology.
- FIG. 9B illustrates the delivery connection assembly 122 and implant 95 of FIG. 8B with the hub 50 of the implant 95 held within the coil 182 .
- FIG. 9B illustrates a stage of detachment in progress.
- FIG. 9B illustrates the implant 95 detached from the delivery connection assembly 122 .
- the implant 95 can be positioned with the delivery connection assembly 122 . While the hub 50 is held within the coil 182 , distally and/or proximally directed forces can be transmitted from the positioner 140 to the hub 50 of the implant 95 .
- a transition of the coil 182 can be achieved to facilitate removal of the coil 182 from engagement with the implant 95 .
- the transition can be achieved as described herein, for example by applying heat to the coil 182 and/or the pusher section 180 .
- the coil 182 can transition from (or from a bias toward) the inner cross-sectional dimension 188 to a second inner cross-sectional dimension 189 that is larger than the hub outer cross-sectional dimension 59 of the hub 50 .
- the inner cross-sectional dimension 188 and the second inner cross-sectional dimension 189 can occur at the same region of the coil 182 at different stages of deployment.
- a transition of the coil 182 can allow the coil 182 to completely disengage from the implant 95 .
- the coil 182 can move proximally and entirely off of the hub 50 .
- the positioner 140 , the microcatheter 14 , and/or the guide catheter 13 can be retracted away from the target implant site and out of the patient, leaving the implant 95 at the target implant site.
- a phrase such as “an aspect” does not imply that such aspect is essential to the subject technology or that such aspect applies to all configurations of the subject technology.
- a disclosure relating to an aspect may apply to all configurations, or one or more configurations.
- An aspect may provide one or more examples of the disclosure.
- a phrase such as “an aspect” may refer to one or more aspects and vice versa.
- a phrase such as “an embodiment” does not imply that such embodiment is essential to the subject technology or that such embodiment applies to all configurations of the subject technology.
- a disclosure relating to an embodiment may apply to all embodiments, or one or more embodiments.
- An embodiment may provide one or more examples of the disclosure.
- a phrase such “an embodiment” may refer to one or more embodiments and vice versa.
- a phrase such as “a configuration” does not imply that such configuration is essential to the subject technology or that such configuration applies to all configurations of the subject technology.
- a disclosure relating to a configuration may apply to all configurations, or one or more configurations.
- a configuration may provide one or more examples of the disclosure.
- a phrase such as “a configuration” may refer to one or more configurations and vice versa.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Surgery (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Vascular Medicine (AREA)
- Medical Informatics (AREA)
- Reproductive Health (AREA)
- Neurosurgery (AREA)
- Anesthesiology (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Surgical Instruments (AREA)
Abstract
Description
- This application claims the benefit of priority of U.S. Provisional Patent Application No. 62/355,431, filed Jun. 28, 2016, which is hereby incorporated by reference in its entirety.
- The subject technology relates to the delivery of implantable medical devices and systems for delivering implantable medical devices.
- The use of endovascular techniques for the implantation of medical devices for treatment, e.g., by occlusion, of body cavities such as arteries, veins, fallopian tubes or vascular deformities is known in the art. For example, vascular aneurysms can be occluded with an implant that is introduced with a pusher member through a catheter. Once advanced to the treatment site, the implant is inserted into the aneurysm cavity to occlude the aneurysm and then detached from the pusher member.
- Detachment of an implant from the pusher member can be problematic. It is essential that the implant form as small a profile as possible to be guided through the fine bore of a catheter and it must be configured to bring about a reliable severance of the implant from the pusher member. Absent a reliable severance of the implant, withdrawal of the pusher member and catheter may cause unintended removal of the implant from the aneurysm or vessel to be occluded, and thus injure and/or rupture of the wall of the aneurysm or vessel.
- A thermally activated detachment mechanism can be employed for controllably releasing an implantable medical device from a delivery connection assembly in a reliable, rapid, and accurate manner. Thermally activated detachment mechanisms can have advantages compared to electrolytic detachment systems. For example, severance of implantable medical devices can involve engagement and disengagement by a delivery connection assembly that minimizes a protruding aspect of the medical devices at an engagement region thereof. The delivery connection assembly can be designed to engage the medical device such that, after disengagement, the mechanisms for engagement are removed with the delivery connection assembly. Such an arrangement can facilitate rapid severance and leave a medical device without an end that protrudes as far as would an implant's connection to an electrolytic detachment junction after detachment.
- In contrast, electrolytic detachment of an implant can leave a portion of the delivery wire protruding from the implant after detachment, presenting a risk of harm to the surrounding anatomy. Additionally, electrolytic detachment can leave behind debris, such as small particulate matter, that can interfere with MRI imaging during a procedure.
- Thermally activated detachment mechanisms also can have advantages compared to mechanical detachment systems. For example, while some mechanical methods for the severance of implants from delivery systems are reliable, mechanical energy must be transmitted (e.g., by rotation of the delivery wire), which may cause the implant to be dislodged out of the correct position. A thermally activated detachment system can avoid the need for transmission of mechanical energy.
- The subject technology is illustrated, for example, according to various aspects described below. Various examples of aspects of the subject technology are described as numbered clauses (1, 2, 3, etc.) for convenience. These are provided as examples and do not limit the subject technology.
- Clause 1. A delivery system, comprising:
-
- an implant comprising (i) a proximal portion that defines a port at a proximal end of the implant and having a port inner cross-sectional dimension and (ii) a cavity distal to the port and having a cavity inner cross-sectional dimension, larger than the port inner cross-sectional dimension; and
- a pusher device comprising arms extending distally from a junction of the pusher device and through the port, with distal sections of the arms disposed within the cavity, the arms having a first configuration in which the distal sections are a first distance apart to define a first outer cross-sectional dimension, larger than the port inner cross-sectional dimension, the arms having a second configuration in which the distal sections are a second distance apart to define a second outer cross-sectional dimension, smaller than the port inner cross-sectional dimension, and the arms being configured to transition from the first configuration to the second configuration when above a transition temperature.
- Clause 2. The delivery system of clause 1, wherein each of the arms comprises a longitudinal section extending from the junction to the distal section.
- Clause 3. The delivery system of any one of clauses 1-2, wherein the distal sections extend radially outwardly.
- Clause 4. The delivery system of any one of clauses 1-3, wherein the distal sections define a maximum outer cross-sectional dimension of a distal region of the pusher device.
- Clause 5. The delivery system of any one of clauses 1-4, wherein the arms are of a shape memory material.
- Clause 6. The delivery system of any one of clauses 1-5, further comprising a heating element thermally connected to the pusher device.
- Clause 7. The delivery system of any one of clauses 1-6, further comprising an electrical circuit thermally connected to the pusher device.
- Clause 8. The delivery system of any one of clauses 1-7, wherein the proximal portion of the implant is a circumferentially continuous hub.
- Clause 9. The delivery system of any one of clauses 1-8, wherein the proximal portion of the implant is a helical coil.
-
Clause 10. A method of delivering an implant, the method comprising: -
- positioning the implant at a target location within a patient while the implant is attached to a pusher device, wherein the implant comprises (i) a proximal portion that defines a port at a proximal end of the implant and having a port inner cross-sectional dimension and (ii) a cavity distal to the port and having a cavity inner cross-sectional dimension, larger than the port inner cross-sectional dimension, wherein the pusher device comprises arms extending distally from a junction of the pusher device and through the port, with distal sections of the arms disposed within the cavity; and
- releasing the implant from the pusher device by increasing a temperature of the arms, such that the arms transition from (i) a first configuration in which the distal sections are a first distance apart to define a first outer cross-sectional dimension, larger than the port inner cross-sectional dimension to (ii) a second configuration in which the distal sections are a second distance apart to define a second outer cross-sectional dimension, smaller than the port inner cross-sectional dimension.
- Clause 11. The method of
clause 10, wherein the releasing comprises operating a heating element thermally connected to the pusher device. -
Clause 12. The method of any one of clauses 10-11, wherein the releasing comprises conducting an electrical current through the pusher device. - Clause 13. The method of any one of clauses 10-12, wherein the releasing comprises retracting the distal sections of the arms proximally from the cavity through the port.
-
Clause 14. The method of clause 13, wherein the releasing further comprises, while retracting the distal sections of the arms, stabilizing the implant with a catheter housing at least a portion of the pusher device. - Clause 15. The method of any one of clauses 10-14, wherein the releasing comprises articulating the arms with respect to the junction.
-
Clause 16. A delivery system, comprising: -
- an implant comprising a proximal portion that defines an outer cross-sectional dimension; and
- a pusher device comprising a coil extending helically about the proximal portion;
- wherein the coil has a first configuration in which the coil is biased to form a lumen with a first inner cross-sectional dimension, smaller than the outer cross-sectional dimension of the proximal portion;
- wherein the coil has a second configuration in which the lumen of the coil has a second inner cross-sectional dimension, larger than the outer cross-sectional dimension of the proximal portion;
- wherein the coil is configured to transition from the first configuration to the second configuration when above a transition temperature.
- Clause 17. The delivery system of
clause 16, wherein at least a portion of the coil extends distally of an entire length of the proximal portion. -
Clause 18. The delivery system of any one of clauses 16-17, wherein the coil is of a shape memory material. - Clause 19. The delivery system of any one of clauses 16-18, further comprising a heating element thermally connected to the pusher device.
-
Clause 20. The delivery system of any one of clauses 16-19, further comprising an electrical circuit thermally connected to the pusher device. - Clause 21. The delivery system of any one of clauses 16-20, wherein the proximal portion of the implant is a circumferentially continuous hub.
-
Clause 22. A method of delivering an implant, the method comprising: -
- positioning the implant at a target location within a patient while the implant is attached to a pusher device, wherein the implant comprises a proximal portion that defines an outer cross-sectional dimension, wherein the pusher device comprises a coil extending helically about the proximal portion; and
- releasing the implant from the pusher device by increasing a temperature of the coil, such that the coil transitions from (i) a first configuration in which the coil is biased to form a lumen with a first inner cross-sectional dimension, smaller than the outer cross-sectional dimension of the proximal portion to (ii) a second configuration in which the lumen of the coil has a second inner cross-sectional dimension, larger than the outer cross-sectional dimension of the proximal portion.
- Clause 23. The method of
clause 22, wherein the releasing comprises operating a heating element thermally connected to the pusher device. - Clause 24. The method of any one of clauses 22-23, wherein the releasing comprises conducting an electrical current through the coil.
- Clause 25. The method of any one of clauses 22-24, wherein the releasing comprises retracting the coil proximally from the implant.
- Additional features and advantages of the subject technology will be set forth in the description below, and in part will be apparent from the description, or may be learned by practice of the subject technology. The advantages of the subject technology will be realized and attained by the structure particularly pointed out in the written description and claims hereof as well as the appended drawings.
- It is to be understood that both the foregoing general description and the following detailed description are exemplifying and explanatory and are intended to provide further explanation of the subject technology as claimed.
- The accompanying drawings, which are included to provide further understanding of the subject technology and are incorporated in and constitute a part of this description, illustrate aspects of the subject technology and, together with the specification, serve to explain principles of the subject technology.
-
FIG. 1A shows a plan view of a delivery system in accordance with some embodiments of the subject technology. -
FIG. 1B shows an enlarged view of a distal portion ofFIG. 1A , in accordance with one or more embodiments of the present disclosure. -
FIG. 2A shows a perspective side view of a braid ball implant, in accordance with one or more embodiments of the subject technology. -
FIG. 2B shows a sectional view of the braid ball implant ofFIG. 2B , in accordance with one or more embodiments of the subject technology. -
FIG. 3 shows in partial cross-section a portion of the delivery system and the braid ball implant ofFIGS. 2A-2B , in accordance with some embodiments of the subject technology. -
FIG. 4 shows a partial sectional view of a distal end of the delivery system ofFIG. 1A connected to a proximal portion of the braid ball implant ofFIGS. 2A-2B , in accordance with one or more embodiments of the subject technology. -
FIG. 5A shows a sectional view of the distal end of the delivery system and proximal portion of the braid ball implant ofFIG. 4 , in accordance with one or more embodiments of the present disclosure. -
FIG. 5B shows a sectional view of the distal end of the delivery system and proximal portion of the braid ball implant ofFIG. 4 , in accordance with one or more embodiments of the present disclosure. -
FIG. 5C shows a sectional view of the distal end of the delivery system and proximal portion of the braid ball implant ofFIG. 4 , in accordance with one or more embodiments of the present disclosure. -
FIG. 6 shows a partial sectional view of a distal end of a delivery system and a proximal portion of a coil implant, in accordance with one or more embodiments of the subject technology. -
FIG. 7 shows a view of a delivery system in partial cross-section and the braid ball implant ofFIGS. 2A-2B , in accordance with some embodiments of the subject technology. -
FIG. 8A shows a side view of a distal end of a delivery system and a proximal portion of an implant, in accordance with one or more embodiments of the subject technology. -
FIG. 8B shows a partial sectional view of the distal end of the delivery system and proximal portion of the implant ofFIG. 8A , in accordance with one or more embodiments of the subject technology. -
FIG. 9A shows a sectional view of the distal end of the delivery system and the proximal portion of the implant ofFIG. 8A , in accordance with one or more embodiments of the present disclosure. -
FIG. 9B shows a sectional view of the distal end of the delivery system and the proximal portion of the implant ofFIG. 8A , in accordance with one or more embodiments of the present disclosure. - The detailed description set forth below is intended as a description of various configurations of the subject technology and is not intended to represent the only configurations in which the subject technology may be practiced. The appended drawings are incorporated herein and constitute a part of the detailed description. The detailed description includes specific details for the purpose of providing a thorough understanding of the subject technology. However, the subject technology may be practiced without these specific details. In some instances, well-known structures and components are shown in block diagram form in order to avoid obscuring the concepts of the subject technology.
- An implantable medical device, e.g., a vascular implant, may be positioned using a
delivery system 10 such as, for example, the one shown inFIGS. 1A-1B . As illustrated inFIGS. 1A-1B for example, thedelivery system 10 can include anactuator 20, apositioner 40 coupled with theactuator 20, and a delivery connection assembly (not shown) extending from theactuator 20 and within thepositioner 40. A portion of adelivery system 10 may engage a complementary portion of animplant 95 in order to control the delivery and detachment of theimplant 95 at the desired location. - A
power supply 70 can be coupled to a proximal portion of thepositioner 40, for example at theactuator 20. A current can flow from thepower supply 70 along afirst lead 72 to a location near theimplant 95 and along asecond lead 74 from the location near theimplant 95 to thepower supply 70. Thepower supply 70 may be a direct current power supply, an alternating current power supply, or a power supply switchable between a direct current and an alternating current. A positive terminal of thepower supply 70, for example as shown inFIG. 1A , may be coupled to thefirst lead 72, and a negative terminal of thepower supply 70 may be coupled to thesecond lead 74. Thepower supply 70 may provide a current through thedelivery system 10 to initiate a heating process during use of thedelivery system 10 to release theimplant 95, as discussed further herein. According to some embodiments, thepower supply 70 can include an electrical generator configured to output an electrical current that is sufficient to actuate thedelivery system 10 to release theimplant 95. Thepower supply 70 can include a suitable controller that can be used to control various parameters of the energy output by the generator, such as intensity, amplitude, duration, frequency, duty cycle, and polarity. - According to some embodiments, for example as shown in
FIGS. 2A-2B , animplant 95 delivered by thedelivery system 10 can be or include abraid ball 92. While theimplant 95 is shown or described in several embodiments as comprising abraid ball 92, any implant or device that is compatible with the subject technology may be used in lieu of or in conjunction with theexample implant 95 disclosed herein, in accordance with the embodiments described herein. Suitable implants and devices include, but are not limited to, stents, filters, thrombectomy devices, atherectomy devices, flow restoration devices, embolic coils, spherical devices, embolic protection devices, or other well-known treatment devices. - The
braid ball 92 can be formed from tubular braid stock including a resilient material, such as nitinol, that defines an open volume in an uncompressed/unconstrained state. The size of the implant can be selected to fill an aneurysm when expanded therein. Theimplant 95 can include ahub 50 and layers 26, 28. The hub can be located at aproximal portion 53 of the implant. Thehub 50 can be fixedly attached to the remainder of theimplant 95. For example, thehub 50 can grasp braided filaments of the 26, 28 of thelayers implant 95. Theimplant 95 can include the 26, 28 at least where impacted by flow at a neck of the aneurysm.layers - According to some embodiments, the
hub 50 can be fixedly attached to the remainder of theimplant 95. For example, thehub 50 can grasp braided filaments of the 26, 28 of thelayers implant 95. Aport 54 can be provided within thehub 50. Theport 54 can define a port innercross-sectional dimension 58. The port innercross-sectional dimension 58 can be a minimum or maximum inner cross-sectional dimension within a region of theproximal portion 53. For example, a region distal to thehub 50 can include acavity 96 that defines an innercross-sectional dimension 98 that is greater than the port innercross-sectional dimension 58. Thehub 50 can further define a hub outercross-sectional dimension 59. The hub outercross-sectional dimension 59 can be a minimum or maximum outer cross-sectional dimension within a region of theproximal portion 53. For example, a region distal to thehub 50 can define an outercross-sectional dimension 57 that is smaller than the hub outercross-sectional dimension 59. Theport 54 or an outer surface of thehub 50 can accept theimplant 95. Delivery system construction and further optional details of theimplant 95 are provided below.FIG. 3 shows thebraid ball 92 attached to adistal end 22 of thedelivery system 10, and positioned within ananeurysm 16. Thedelivery system 10 extends proximally from theimplant 95 to a location outside of the body where the delivery system can be manipulated by a user. As illustrated inFIG. 3 , thedelivery system 10 can comprise amicrocatheter 14 and a delivery connection assembly that includes thepositioner 40. Themicrocatheter 14 is advanced until its distal end is in the vicinity of a target site, such as theaneurysm 16, for example as shown inFIG. 3 . Thepositioner 40 is advanced within themicrocatheter 14 to access the target site. Thepositioner 40 can be advanced out of themicrocatheter 14 and directed to the target site. Theimplant 95 can be advanced with thepositioner 40 until theimplant 95 is positioned at the target site. - The
delivery system 10 and themicrocatheter 14 can have lengths sufficient to extend from outside the patient's body to a target location in the brain. For example, each of them can be at least 125 cm long, and more particularly may be between about 125 cm and about 175 cm long, with thedelivery system 10 being longer than themicrocatheter 14. Typically themicrocatheter 14 is about 155 cm long. Commercially available microcatheters which may be suitable for use as delivery catheters include the REBAR™ Reinforced Micro Catheter, which is available from Medtronic, Inc. and the MARKSMAN™ Catheter, which is available from Medtronic, Inc. - When the
delivery system 10 has been advanced to atarget aneurysm 16, theimplant 95 can be inserted within theaneurysm 16 and expanded to a fully deployed state, for example as illustrated inFIG. 3 . The position of theimplant 95 can be affected and/or modified by corresponding motion of thedelivery system 10. A radiopaque marker (e.g., the hub 50) of theimplant 95 can be utilized to track and confirm delivery of theimplant 95 to the target location. - According to some embodiments, the
implant 95 is supported during delivery by adelivery connection assembly 12, from which theimplant 95 can also be detached. According to some embodiments, for example as shown inFIG. 4 , thedelivery connection assembly 12 can include thepositioner 40, apusher device 78 and aheating element 76. Thepusher device 78 can include one ormore arms 82 that engage theimplant 95. Theheating element 76 can controllably provide heat to thepusher device 78 to actuate the arms until thearms 82 released theimplant 95. - According to some embodiments, the
pusher device 78 can include one ormore arms 82 extending distally from ajunction 80 of thepusher device 78 and through theport 54. One or more of thearms 82 can include adistal section 84 that can be positioned distal to at least a portion of theport 54 and/or within acavity 96 of theimplant 95. According to some embodiments, thearms 82 can extend longitudinally from thejunction 80, and thedistal sections 84 can extend radially outwardly from thearms 82. In at least one configuration, thedistal sections 84 can define a maximum outercross-sectional dimension 86 that is greater than the port innercross-sectional dimension 58. Accordingly, passage of thedistal sections 84 proximally through theport 54 is resisted until thedistal sections 84 are transitioned to a different configuration. - According to some embodiments, the
arms 82 are configured to flex, bend, pivot, or articulate with respect to thejunction 80 in response to temperature changes. Such action can be achieved based on a programmed characteristic of thearms 82. When thearms 82 are at or above a transition temperature, thearms 82 can transition to a second configuration, such as an austenite state in a shape memory alloy, in which thearms 82 in a relaxed state can disengage from theimplant 95, as will be more fully described herein. - The transition temperature at which the
arms 82 begin to revert to the second configuration can be selected at the typical human body temperature (i.e., about 36.7° C. or 98° F.) or another temperature. The transition temperature can be selected above the typical human body temperature, and the transition temperature can be achieved in thearms 82 by an application of heat other than from the body. Exemplifying materials for use in the composition of thejunction 80 and/or thearms 82 can include nickel-titanium (nitinol), copper-tin, copper-zinc, copper-zinc-tin, copper-zinc-xenon, copper-aluminum-nickel, copper-gold-zinc, gold-cadmium, gold-copper-zinc, iron-beryllium, iron-platinum, indium-thallium, iron-manganese, iron-nickel-titanium-cobalt, nickel-titanium-vanadium, silver-cadmium, and combinations thereof. Exemplifying materials can further include a shape memory polymer, such as polyurethane, polyethylene terephthalate (PET), or high density polyethylene (HDPE). - According to some embodiments, for example as shown in
FIG. 4 , aheating element 76 can be provided in thermal connection with thejunction 80 and thearms 82. Theheating element 76 can be connected to thepower supply 70 via the first and second leads 72, 74 to direct a current through theheating element 76. The leads 72, 74 can extend alongside thepusher device 78 within a lumen of thepositioner 40 and proximally from theheating element 76 to outside the patient's body. - At least a portion of the
heating element 76 can provide an electrical circuit with adequate resistance to generate heat while electrical current is applied. Theheating element 76 can include a number of coil windings about a portion of thepusher device 78, for example as illustrated inFIG. 4 . Theheating element 76 can contact or be in close proximity to one or more of thejunction 80 and thearms 82. For example, theheating element 76 can be adjacent to or overlap with one or more of thejunction 80 and thearms 82. Heat generated by theheating element 76 can be conducted to achieve an increase in temperature along one or more portions of thepusher device 78. Alternatively or in combination, theheating element 76 can include other heat transmission elements such as a heat pipe that transfers heat via convention of heat transfer media therethrough or a fiber optic cable that transfers heat via transmission of light. Alternatively or in combination, thearms 82 and/or thejunction 80 may serve as a heating element by directing an electrical current therethrough. -
FIGS. 5A-5C illustrate various stages of an exemplifying method according to one or more embodiments of the subject technology.FIG. 5A illustrates thedelivery connection assembly 12 andimplant 95 ofFIG. 4 with thehub 50 of the implant held between thepusher device 78 and thepositioner 40.FIG. 5B illustrates a stage of detachment in progress.FIG. 5C illustrates theimplant 95 detached from thedelivery system 10. - According to some embodiments, the
implant 95 can be positioned with thepositioner 40 and thepusher device 78. Distally directed forces can be transmitted from thepositioner 40 to thehub 50 of theimplant 95. Additionally, proximally directed forces can be transmitted from thepusher device 78 to thehub 50 of theimplant 95. - According to some embodiments, for example as shown in
FIGS. 5A and 5B , a transition of thearms 82 can be achieved to facilitate removal of thearms 82 from engagement with theimplant 95. The transition can be achieved as described herein, for example by applying heat to thearms 82 and/or thejunction 80. As a result of the transition, thedistal sections 84 can transition (e.g., move inwardly as illustrated inFIGS. 5A and 5B ) from the maximum outercross-sectional dimension 86 to a second maximum outercross-sectional dimension 88 that is smaller than the port innercross-sectional dimension 58. - According to some embodiments, for example as shown in
FIGS. 5B and 5C , the transition of the arms 82 (e.g., inward movement of the arms 82) can allow thearms 82 to completely disengage from theimplant 95. For example, thearms 82 can move proximally through theport 54 such that thedistal sections 84 are entirely proximal of theimplant 95. During proximal retraction of thepusher device 78, thepositioner 40 can stabilize theimplant 95, for example by applying a distally directed force while thepositioner 40 contacts thehub 50. Upon full disengagement by thepusher device 78, thepusher device 78, thepositioner 40, the microcatheter 14 (if employed), and/or a guide catheter 13 (if employed) can be retracted away from the target implant site and out of the patient, leaving theimplant 95 at the target implant site. - Although
FIGS. 4-5C illustrate animplant 95 comprising abraid ball 92, thedelivery system 10 can be used with acoil implant 90, for example as illustrated in part in FIG. 6, according to one or more embodiments of the subject technology. Therefore, thepositioner 40 and other elements and components of thedelivery system 10 are neither illustrated inFIG. 6 nor described again in detail with reference toFIG. 6 , as these components can be readily understood from the other disclosure of them herein. - According to some embodiments, for example as shown in
FIG. 6 , thepusher device 78 can be configured to engage acoil implant 90. Thecoil implant 90 can include aproximal portion 102 and adistal portion 104. Theproximal portion 102 can be smaller than thedistal portion 104 and reside at least partially within acavity 196 of thedistal portion 104, such that theproximal portion 102 and thedistal portion 104 at least partially overlap. Theproximal portion 102 and thedistal portion 104 can form separate portions of a continuous helical coil. Alternatively, theproximal portion 102 and thedistal portion 104 can be separate structures that are joined together by an intervening structure. AlthoughFIG. 6 illustrates theproximal portion 102 and thedistal portion 104 as coils, theproximal portion 102 and/or thedistal portion 104 can also form another circumferentially continuous structure, such as a cylindrical tube as an alternative to a helical coil or in combination with a helical coil. - The
proximal portion 102 can be disposed at the proximal end of thedistal portion 104 and can further define aport 154. Theport 154 can extend completely through theproximal portion 102. Theport 154 can be large enough to receive thearms 82 of thepusher device 78. Theport 154 can define a port innercross-sectional dimension 158. The port innercross-sectional dimension 158 can be a minimum or maximum inner cross-sectional dimension within a region of theproximal portion 102. For example, a region distal to theproximal portion 102 can include acavity 196 that defines an innercross-sectional dimension 198 that is greater than the port innercross-sectional dimension 158. - According to some embodiments, for example as shown in
FIG. 6 , one or more of thedistal sections 84 can be positioned distal to at least a portion of theport 154 and/or within thecavity 196 of thecoil implant 90. In at least one configuration, thedistal sections 84 can define a maximum outercross-sectional dimension 86 that is greater than the port innercross-sectional dimension 158. According to some embodiments, for example as shown inFIG. 6 , thedistal sections 84 can extend into one or more gaps between windings of thedistal portion 104 of thecoil implant 90. For example, thedistal sections 84 can define a maximum outercross-sectional dimension 86 that is greater than the innercross-sectional dimension 198 of thedistal portion 104. Accordingly, passage of thedistal sections 84 proximally through theport 154 is resisted until thedistal sections 84 are transitioned to a different configuration. - Although
FIGS. 3-6 illustrate thedelivery system 10 engaging theimplant 95 within a cavity thereof, adelivery system 110 can be used to engage an outer portion of theimplant 95, for example as illustrated in part inFIG. 7 , according to one or more embodiments of the subject technology. Referring now toFIG. 7 , theimplant 95 can be attached to adistal end 121 of thedelivery system 110, and positioned within ananeurysm 16. As illustrated inFIG. 7 , thedelivery system 110 can comprise amicrocatheter 14 and a delivery connection assembly that includes thepositioner 140. Themicrocatheter 14 is advanced until its distal end is in the vicinity of a target site, such as theaneurysm 16, for example as shown inFIG. 7 . Thepositioner 140 is advanced within thecatheter 14 to access the target site. -
FIG. 8A shows an enlarged view of thedistal end 121 of thedelivery system 110 and a proximal portion of theimplant 95 ofFIG. 7 .FIG. 8B shows a partial sectional view of thedistal end 121 of thedelivery system 110 and the proximal portion of theimplant 95 shown inFIG. 8 .FIGS. 8A and 8B show theimplant 95 supported during delivery by adelivery connection assembly 122, from which theimplant 95 can also be detached. Thedelivery connection assembly 122 can include fewer components than thedelivery connection assembly 12, described above. According to some embodiments, for example as shown inFIGS. 8A and 8B , thedelivery connection assembly 122 can include thepositioner 140 and one ormore coils 182 extending helically and distally from apusher section 180 of thepositioner 140. - The
coil 182 can be positioned to extend about an outer periphery of a portion of theimplant 95. For example, thecoil 182 can wrap up around and engage thehub 50 of theimplant 95. Thecoil 182 can extend proximal to thehub 50, along a length of thehub 50, and/or distal to thehub 50. For example, thecoil 182 can extend to regions on one or both sides of thehub 50. A distalmost region of thecoil 182 can engage a distal end of thehub 50. A proximalmost region of thecoil 182 can engage a proximal end of thehub 50. Alternatively, a separate structure of thedelivery connection assembly 122, e.g., a stop, can engage a proximal end of thehub 50. - The
coil 182 can be affixed to thepusher section 180 of thepositioner 140, such that movement of thepusher section 180 substantially transmit forces to thecoil 182 and theimplant 95. In at least one configuration, thecoil 182 can be biased to form an innercross-sectional dimension 188 that is smaller than the hub outercross-sectional dimension 59. The bias of thecoil 182 can refer to the tendency of thecoil 182, in a relaxed configuration, to naturally move to a shape in which it forms the innercross-sectional dimension 188. Despite this bias, thecoil 182 may be prevented from completely achieving the shape of the relaxed configuration and instead engage thehub 50. While engaged on thehub 50, at least a portion of thecoil 182 may have an innercross-sectional dimension 188 that is equal to the hub outercross-sectional dimension 59 of thehub 50. The bias can provide a force of engagement with thehub 50. Accordingly, movement of thehub 50 is limited or resisted until thecoil 182 is transitioned to a different configuration. - According to some embodiments, the
coil 182 is configured to flex, bend, unwind, and/or radially expand. Such action can be achieved based on a programmed characteristic of thecoil 182. When thecoil 182 is at or above a transition temperature, thecoil 182 can transition to a second configuration, such as an austenite state in a shape memory alloy, in which thecoil 182 in a relaxed state can disengage from theimplant 95, as will be more fully described herein. - The transition temperature at which the
coil 182 begins to revert to the second configuration can be selected at the typical human body temperature (i.e., about 36.7° C. or 98° F.) or another temperature. The transition temperature can be selected above the typical human body temperature, and the transition temperature can be achieved in thecoil 182 by an application of heat other than from the patient's body. Exemplifying materials for use in the composition of thecoil 182 can include nickel-titanium (nitinol), copper-tin, copper-zinc, copper-zinc-tin, copper-zinc-xenon, copper-aluminum-nickel, copper-gold-zinc, gold-cadmium, gold-copper-zinc, iron-beryllium, iron-platinum, indium-thallium, iron-manganese, iron-nickel-titanium-cobalt, nickel-titanium-vanadium, silver-cadmium, and combinations thereof. Exemplifying materials can further include a shape memory polymer, such as polyurethane, polyethylene terephthalate (PET), or high density polyethylene (HDPE). - According to some embodiments, for example as shown in
FIG. 8B , aheating element 176 can be provided in thermal connection with thepusher section 180 and thecoil 182. Theheating element 176 can be connected to thepower supply 70 via the first and 172, 174 to direct a current through thesecond leads heating element 176. The leads 172, 174 can extend within a lumen of thepositioner 140 and proximally from theheating element 176 to outside the patient's body. - At least a portion of the
heating element 176 can provide an electrical circuit with adequate resistance to generate heat while electrical current is applied. Theheating element 176 can include a number of coil windings within a portion of thepositioner 140, for example as illustrated inFIG. 8B . Theheating element 176 can contact or be in close proximity to one or more of thepusher section 180 and thecoil 182. For example, theheating element 176 can be adjacent to or overlap with one or more of thepusher section 180 and thecoil 182. Heat generated by theheating element 176 can be conducted to achieve an increase in temperature along one or more portions of thepositioner 140. Alternatively or in combination, theheating element 176 can include other heat transmission elements such as a heat pipe that transfers heat via convention of heat transfer media therethrough or a fiber optic cable that transfers heat via transmission of light. Alternatively or in combination, thecoil 182 and/or thepusher section 180 may serve as a heating element by directing an electrical current therethrough. - While the
coil 182 can be a single filament helical winding, as shown inFIGS. 8A and 8B , other shapes for engaging theimplant 95 are contemplated. According to some embodiments, thecoil 182 can include multiple filaments that are the same or different sizes. The filaments can be wound in the same direction or counter wound. The filaments can be provided in a single layer or in multiple concentric layers. Alternatively or in combination, other shapes can be used to engage theimplant 95, such as a circumferentially continuous structure, such as a cylindrical tube. -
FIGS. 9A and 9B illustrate various stages of an exemplifying method according to one or more embodiments of the subject technology.FIG. 9B illustrates thedelivery connection assembly 122 andimplant 95 ofFIG. 8B with thehub 50 of theimplant 95 held within thecoil 182.FIG. 9B illustrates a stage of detachment in progress.FIG. 9B illustrates theimplant 95 detached from thedelivery connection assembly 122. - According to some embodiments, the
implant 95 can be positioned with thedelivery connection assembly 122. While thehub 50 is held within thecoil 182, distally and/or proximally directed forces can be transmitted from thepositioner 140 to thehub 50 of theimplant 95. According to some embodiments, for example as shown inFIGS. 9A and 9B , a transition of thecoil 182 can be achieved to facilitate removal of thecoil 182 from engagement with theimplant 95. The transition can be achieved as described herein, for example by applying heat to thecoil 182 and/or thepusher section 180. As a result of the transition, thecoil 182 can transition from (or from a bias toward) the innercross-sectional dimension 188 to a second inner cross-sectional dimension 189 that is larger than the hub outercross-sectional dimension 59 of thehub 50. The innercross-sectional dimension 188 and the second inner cross-sectional dimension 189 can occur at the same region of thecoil 182 at different stages of deployment. - According to some embodiments, for example as shown in
FIGS. 9A and 9B , a transition of thecoil 182 can allow thecoil 182 to completely disengage from theimplant 95. For example, thecoil 182 can move proximally and entirely off of thehub 50. Upon full disengagement by thepositioner 140, thepositioner 140, themicrocatheter 14, and/or the guide catheter 13 can be retracted away from the target implant site and out of the patient, leaving theimplant 95 at the target implant site. - The foregoing description is provided to enable a person skilled in the art to practice the various configurations described herein. While the subject technology has been particularly described with reference to the various figures and configurations, it should be understood that these are for illustration purposes only and should not be taken as limiting the scope of the subject technology.
- There may be many other ways to implement the subject technology. Various functions and elements described herein may be partitioned differently from those shown without departing from the scope of the subject technology. Various modifications to these configurations will be readily apparent to those skilled in the art, and generic principles defined herein may be applied to other configurations. Thus, many changes and modifications may be made to the subject technology, by one having ordinary skill in the art, without departing from the scope of the subject technology.
- It is understood that the specific order or hierarchy of steps in the processes disclosed is an illustration of exemplifying approaches. Based upon design preferences, it is understood that the specific order or hierarchy of steps in the processes may be rearranged. Some of the steps may be performed simultaneously. The accompanying method claims present elements of the various steps in a sample order, and are not meant to be limited to the specific order or hierarchy presented.
- A phrase such as “an aspect” does not imply that such aspect is essential to the subject technology or that such aspect applies to all configurations of the subject technology. A disclosure relating to an aspect may apply to all configurations, or one or more configurations. An aspect may provide one or more examples of the disclosure. A phrase such as “an aspect” may refer to one or more aspects and vice versa. A phrase such as “an embodiment” does not imply that such embodiment is essential to the subject technology or that such embodiment applies to all configurations of the subject technology. A disclosure relating to an embodiment may apply to all embodiments, or one or more embodiments. An embodiment may provide one or more examples of the disclosure. A phrase such “an embodiment” may refer to one or more embodiments and vice versa. A phrase such as “a configuration” does not imply that such configuration is essential to the subject technology or that such configuration applies to all configurations of the subject technology. A disclosure relating to a configuration may apply to all configurations, or one or more configurations. A configuration may provide one or more examples of the disclosure. A phrase such as “a configuration” may refer to one or more configurations and vice versa.
- Furthermore, to the extent that the term “include,” “have,” or the like is used in the description or the claims, such term is intended to be inclusive in a manner similar to the term “comprise” as “comprise” is interpreted when employed as a transitional word in a claim.
- A reference to an element in the singular is not intended to mean “one and only one” unless specifically stated, but rather “one or more.” The term “some” refers to one or more. All structural and functional equivalents to the elements of the various configurations described throughout this disclosure that are known or later come to be known to those of ordinary skill in the art are expressly incorporated herein by reference and intended to be encompassed by the subject technology. Moreover, nothing disclosed herein is intended to be dedicated to the public regardless of whether such disclosure is explicitly recited in the above description.
- While certain aspects and embodiments of the subject technology have been described, these have been presented by way of example only, and are not intended to limit the scope of the subject technology. Indeed, the novel methods and systems described herein may be embodied in a variety of other forms without departing from the spirit thereof. The accompanying claims and their equivalents are intended to cover such forms or modifications as would fall within the scope and spirit of the subject technology.
Claims (25)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15/610,713 US11051822B2 (en) | 2016-06-28 | 2017-06-01 | Implant detachment with thermal activation |
| US17/303,869 US12357316B2 (en) | 2016-06-28 | 2021-06-09 | Implant detachment with thermal activation |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662355431P | 2016-06-28 | 2016-06-28 | |
| US15/610,713 US11051822B2 (en) | 2016-06-28 | 2017-06-01 | Implant detachment with thermal activation |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US17/303,869 Division US12357316B2 (en) | 2016-06-28 | 2021-06-09 | Implant detachment with thermal activation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| US20170367709A1 true US20170367709A1 (en) | 2017-12-28 |
| US11051822B2 US11051822B2 (en) | 2021-07-06 |
Family
ID=59078243
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US15/610,713 Active 2039-04-12 US11051822B2 (en) | 2016-06-28 | 2017-06-01 | Implant detachment with thermal activation |
| US17/303,869 Active 2039-10-02 US12357316B2 (en) | 2016-06-28 | 2021-06-09 | Implant detachment with thermal activation |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US17/303,869 Active 2039-10-02 US12357316B2 (en) | 2016-06-28 | 2021-06-09 | Implant detachment with thermal activation |
Country Status (2)
| Country | Link |
|---|---|
| US (2) | US11051822B2 (en) |
| WO (1) | WO2018005042A1 (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3603540A1 (en) * | 2018-08-03 | 2020-02-05 | DePuy Synthes Products, Inc. | Spiral delivery system for embolic braid |
| CN112237458A (en) * | 2019-07-19 | 2021-01-19 | 柯惠有限合伙公司 | Embolic device delivery system |
| WO2021010222A1 (en) * | 2019-07-18 | 2021-01-21 | 朝日インテック株式会社 | Implant device |
| CN116211380A (en) * | 2022-07-29 | 2023-06-06 | 杭州亿科医疗科技有限公司 | Spring coil release device convenient to operate |
| US20230218302A1 (en) * | 2020-06-15 | 2023-07-13 | Icahn School Of Medicine At Mount Sinai | Detachment mechanism for detachable-tip endovascular devices |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11051822B2 (en) | 2016-06-28 | 2021-07-06 | Covidien Lp | Implant detachment with thermal activation |
| CN116940311A (en) | 2022-02-23 | 2023-10-24 | 艾露姆技术股份有限公司 | Neurovascular shunt and delivery system |
| US12213676B2 (en) | 2023-02-22 | 2025-02-04 | eLum Technologies, Inc. | Systems and methods for customizable flow diverter implants |
| US12471926B2 (en) | 2023-02-22 | 2025-11-18 | eLum Technologies, Inc. | Systems and methods for customizable flow diverter implants |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5578074A (en) * | 1994-12-22 | 1996-11-26 | Target Therapeutics, Inc. | Implant delivery method and assembly |
| US20050149108A1 (en) * | 2003-12-17 | 2005-07-07 | Microvention, Inc. | Implant delivery and detachment system and method |
| US20100121350A1 (en) * | 2007-04-12 | 2010-05-13 | Greg Mirigian | Instantaneous mechanical detachment mechanism for vaso-occlusive devices |
| US20170035437A1 (en) * | 2015-08-05 | 2017-02-09 | Henry Nita LLC | Devices and Methods for Treatment of Endovascular and Non-Endovascular Defects in Humans Using Occlusion Implants |
Family Cites Families (208)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6083220A (en) | 1990-03-13 | 2000-07-04 | The Regents Of The University Of California | Endovascular electrolytically detachable wire and tip for the formation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas |
| US6425893B1 (en) | 1990-03-13 | 2002-07-30 | The Regents Of The University Of California | Method and apparatus for fast electrolytic detachment of an implant |
| US5851206A (en) | 1990-03-13 | 1998-12-22 | The Regents Of The University Of California | Method and apparatus for endovascular thermal thrombosis and thermal cancer treatment |
| USRE42756E1 (en) | 1990-03-13 | 2011-09-27 | The Regents Of The University Of California | Endovascular electrolytically detachable wire and tip for the formation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas |
| USRE42625E1 (en) | 1990-03-13 | 2011-08-16 | The Regents Of The University Of California | Endovascular electrolytically detachable wire and tip for the formation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas |
| US5354295A (en) | 1990-03-13 | 1994-10-11 | Target Therapeutics, Inc. | In an endovascular electrolytically detachable wire and tip for the formation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas |
| US5122136A (en) | 1990-03-13 | 1992-06-16 | The Regents Of The University Of California | Endovascular electrolytically detachable guidewire tip for the electroformation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas |
| US5108407A (en) | 1990-06-08 | 1992-04-28 | Rush-Presbyterian St. Luke's Medical Center | Method and apparatus for placement of an embolic coil |
| US5509411A (en) | 1993-01-29 | 1996-04-23 | Cardima, Inc. | Intravascular sensing device |
| US5250071A (en) | 1992-09-22 | 1993-10-05 | Target Therapeutics, Inc. | Detachable embolic coil assembly using interlocking clasps and method of use |
| US5925059A (en) | 1993-04-19 | 1999-07-20 | Target Therapeutics, Inc. | Detachable embolic coil assembly |
| US5800453A (en) | 1993-04-19 | 1998-09-01 | Target Therapeutics, Inc. | Detachable embolic coil assembly using interlocking hooks and slots |
| US5370653A (en) | 1993-07-22 | 1994-12-06 | Micro Therapeutics, Inc. | Thrombectomy method and apparatus |
| US5498227A (en) | 1993-09-15 | 1996-03-12 | Mawad; Michel E. | Retrievable, shielded radiotherapy implant |
| US5624449A (en) | 1993-11-03 | 1997-04-29 | Target Therapeutics | Electrolytically severable joint for endovascular embolic devices |
| US5423829A (en) | 1993-11-03 | 1995-06-13 | Target Therapeutics, Inc. | Electrolytically severable joint for endovascular embolic devices |
| US5522836A (en) | 1994-06-27 | 1996-06-04 | Target Therapeutics, Inc. | Electrolytically severable coil assembly with movable detachment point |
| DE4445715C2 (en) | 1994-12-22 | 1998-04-09 | Hans Dr Med Henkes | Arrangement for inserting an implant into a blood vessel or into a body cavity |
| IL116561A0 (en) | 1994-12-30 | 1996-03-31 | Target Therapeutics Inc | Severable joint for detachable devices placed within the body |
| CA2173023C (en) | 1995-03-30 | 2001-08-28 | David Kupiecki | Liquid coils with secondary shape |
| US8790363B2 (en) * | 1995-04-20 | 2014-07-29 | DePuy Synthes Products, LLC | Three dimensional, low friction vasoocclusive coil, and method of manufacture |
| US6059779A (en) | 1995-04-28 | 2000-05-09 | Target Therapeutics, Inc. | Delivery catheter for electrolytically detachable implant |
| US5989242A (en) * | 1995-06-26 | 1999-11-23 | Trimedyne, Inc. | Therapeutic appliance releasing device |
| US5853418A (en) | 1995-06-30 | 1998-12-29 | Target Therapeutics, Inc. | Stretch resistant vaso-occlusive coils (II) |
| US6013084A (en) | 1995-06-30 | 2000-01-11 | Target Therapeutics, Inc. | Stretch resistant vaso-occlusive coils (II) |
| US5743905A (en) | 1995-07-07 | 1998-04-28 | Target Therapeutics, Inc. | Partially insulated occlusion device |
| US5766629A (en) | 1995-08-25 | 1998-06-16 | Sangstat Medical Corporation | Oral cyclosporin formulations |
| US5658308A (en) | 1995-12-04 | 1997-08-19 | Target Therapeutics, Inc. | Bioactive occlusion coil |
| US5749894A (en) | 1996-01-18 | 1998-05-12 | Target Therapeutics, Inc. | Aneurysm closure method |
| US6168622B1 (en) | 1996-01-24 | 2001-01-02 | Microvena Corporation | Method and apparatus for occluding aneurysms |
| US5980514A (en) | 1996-07-26 | 1999-11-09 | Target Therapeutics, Inc. | Aneurysm closure device assembly |
| US5964797A (en) | 1996-08-30 | 1999-10-12 | Target Therapeutics, Inc. | Electrolytically deployable braided vaso-occlusion device |
| US5690667A (en) | 1996-09-26 | 1997-11-25 | Target Therapeutics | Vasoocclusion coil having a polymer tip |
| US5733329A (en) | 1996-12-30 | 1998-03-31 | Target Therapeutics, Inc. | Vaso-occlusive coil with conical end |
| US5944114A (en) | 1997-01-27 | 1999-08-31 | Farley; Brent L. | Devices for constraining wildfires |
| DE19703482A1 (en) | 1997-01-31 | 1998-08-06 | Ernst Peter Prof Dr M Strecker | Stent |
| US5911737A (en) * | 1997-02-28 | 1999-06-15 | The Regents Of The University Of California | Microfabricated therapeutic actuators |
| US5951599A (en) | 1997-07-09 | 1999-09-14 | Scimed Life Systems, Inc. | Occlusion system for endovascular treatment of an aneurysm |
| US5928260A (en) | 1997-07-10 | 1999-07-27 | Scimed Life Systems, Inc. | Removable occlusion system for aneurysm neck |
| US6063070A (en) | 1997-08-05 | 2000-05-16 | Target Therapeutics, Inc. | Detachable aneurysm neck bridge (II) |
| DE69834920T2 (en) | 1997-08-05 | 2007-05-24 | Boston Scientific Ltd., St. Michael | REMOVABLE SYSTEM FOR CLOSING AN ANEURYSMAS NECK |
| US5916235A (en) | 1997-08-13 | 1999-06-29 | The Regents Of The University Of California | Apparatus and method for the use of detachable coils in vascular aneurysms and body cavities |
| US5984929A (en) | 1997-08-29 | 1999-11-16 | Target Therapeutics, Inc. | Fast detaching electronically isolated implant |
| US6156061A (en) | 1997-08-29 | 2000-12-05 | Target Therapeutics, Inc. | Fast-detaching electrically insulated implant |
| US6146373A (en) | 1997-10-17 | 2000-11-14 | Micro Therapeutics, Inc. | Catheter system and method for injection of a liquid embolic composition and a solidification agent |
| US6511468B1 (en) | 1997-10-17 | 2003-01-28 | Micro Therapeutics, Inc. | Device and method for controlling injection of liquid embolic composition |
| US6136015A (en) | 1998-08-25 | 2000-10-24 | Micrus Corporation | Vasoocclusive coil |
| US6241691B1 (en) | 1997-12-05 | 2001-06-05 | Micrus Corporation | Coated superelastic stent |
| US5873907A (en) | 1998-01-27 | 1999-02-23 | Endotex Interventional Systems, Inc. | Electrolytic stent delivery system and methods of use |
| US5935145A (en) | 1998-02-13 | 1999-08-10 | Target Therapeutics, Inc. | Vaso-occlusive device with attached polymeric materials |
| US5941888A (en) | 1998-02-18 | 1999-08-24 | Target Therapeutics, Inc. | Vaso-occlusive member assembly with multiple detaching points |
| US6077260A (en) | 1998-02-19 | 2000-06-20 | Target Therapeutics, Inc. | Assembly containing an electrolytically severable joint for endovascular embolic devices |
| US6168615B1 (en) | 1998-05-04 | 2001-01-02 | Micrus Corporation | Method and apparatus for occlusion and reinforcement of aneurysms |
| JP4037958B2 (en) | 1998-05-11 | 2008-01-23 | 日清紡績株式会社 | Thermosetting resin composition |
| US5935148A (en) | 1998-06-24 | 1999-08-10 | Target Therapeutics, Inc. | Detachable, varying flexibility, aneurysm neck bridge |
| US6165193A (en) | 1998-07-06 | 2000-12-26 | Microvention, Inc. | Vascular embolization with an expansible implant |
| US6296622B1 (en) | 1998-12-21 | 2001-10-02 | Micrus Corporation | Endoluminal device delivery system using axially recovering shape memory material |
| US6478773B1 (en) | 1998-12-21 | 2002-11-12 | Micrus Corporation | Apparatus for deployment of micro-coil using a catheter |
| WO2000013593A1 (en) | 1998-09-04 | 2000-03-16 | Boston Scientific Limited (Incorporated In Ireland) | Detachable aneurysm neck closure patch |
| US6723112B2 (en) | 1998-11-10 | 2004-04-20 | Scimed Life Systems, Inc. | Bioactive three loop coil |
| US6835185B2 (en) | 1998-12-21 | 2004-12-28 | Micrus Corporation | Intravascular device deployment mechanism incorporating mechanical detachment |
| US7018401B1 (en) | 1999-02-01 | 2006-03-28 | Board Of Regents, The University Of Texas System | Woven intravascular devices and methods for making the same and apparatus for delivery of the same |
| ATE377395T1 (en) * | 1999-06-02 | 2007-11-15 | Sethel Interventional Inc | INTRACORPORAL CLOSURE DEVICE |
| US6280457B1 (en) | 1999-06-04 | 2001-08-28 | Scimed Life Systems, Inc. | Polymer covered vaso-occlusive devices and methods of producing such devices |
| US6309367B1 (en) | 1999-07-23 | 2001-10-30 | Neurovasx, Inc. | Aneurysm shield |
| US6602261B2 (en) | 1999-10-04 | 2003-08-05 | Microvention, Inc. | Filamentous embolic device with expansile elements |
| US6238403B1 (en) | 1999-10-04 | 2001-05-29 | Microvention, Inc. | Filamentous embolic device with expansible elements |
| DE10010840A1 (en) | 1999-10-30 | 2001-09-20 | Dendron Gmbh | Device for implanting occlusion coils uses coils electrolytically corrodable at several points at intervals so variable sized lengths can be separated by electrolysis |
| US8048104B2 (en) | 2000-10-30 | 2011-11-01 | Dendron Gmbh | Device for the implantation of occlusion spirals |
| US6331184B1 (en) | 1999-12-10 | 2001-12-18 | Scimed Life Systems, Inc. | Detachable covering for an implantable medical device |
| US7740637B2 (en) | 2000-02-09 | 2010-06-22 | Micrus Endovascular Corporation | Apparatus and method for deployment of a therapeutic device using a catheter |
| US6632241B1 (en) | 2000-03-22 | 2003-10-14 | Endovascular Technologies, Inc. | Self-expanding, pseudo-braided intravascular device |
| US6468301B1 (en) | 2000-03-27 | 2002-10-22 | Aga Medical Corporation | Repositionable and recapturable vascular stent/graft |
| US20030176857A1 (en) | 2000-07-26 | 2003-09-18 | Lee Kyu Ho | Assembly for embolic treatments |
| US6605101B1 (en) | 2000-09-26 | 2003-08-12 | Microvention, Inc. | Microcoil vaso-occlusive device with multi-axis secondary configuration |
| US6416373B1 (en) | 2000-10-12 | 2002-07-09 | Bombardier Motor Corporation Of America | Oil system vent with remote oil reservoir |
| US6743251B1 (en) | 2000-11-15 | 2004-06-01 | Scimed Life Systems, Inc. | Implantable devices with polymeric detachment junction |
| US8721625B2 (en) | 2001-01-26 | 2014-05-13 | Cook Medical Technologies Llc | Endovascular medical device with plurality of wires |
| US6494884B2 (en) | 2001-02-09 | 2002-12-17 | Concentric Medical, Inc. | Methods and devices for delivering occlusion elements |
| US6878384B2 (en) | 2001-03-13 | 2005-04-12 | Microvention, Inc. | Hydrogels that undergo volumetric expansion in response to changes in their environment and their methods of manufacture and use |
| DE10118017B4 (en) | 2001-04-10 | 2017-04-13 | Dendron Gmbh | Occlusion coil and device for implantation of occlusion coils |
| ATE516759T1 (en) | 2001-05-29 | 2011-08-15 | Microvention Inc | METHOD FOR PRODUCING EXPANDABLE FILAMENTOUS EMBOLIZATION DEVICES |
| CA2449137A1 (en) | 2001-06-01 | 2002-12-05 | Jean Raymond | Detachable tip microcatheter for use of liquid embolic agents |
| US8715312B2 (en) | 2001-07-20 | 2014-05-06 | Microvention, Inc. | Aneurysm treatment device and method of use |
| US7572288B2 (en) | 2001-07-20 | 2009-08-11 | Microvention, Inc. | Aneurysm treatment device and method of use |
| US8252040B2 (en) | 2001-07-20 | 2012-08-28 | Microvention, Inc. | Aneurysm treatment device and method of use |
| US20030028209A1 (en) | 2001-07-31 | 2003-02-06 | Clifford Teoh | Expandable body cavity liner device |
| US7687053B2 (en) | 2001-08-20 | 2010-03-30 | Boston Scientific Scimed, Inc. | Embolic compositions with non-cyanoacrylate rheology modifying agents |
| EP1420701B1 (en) | 2001-08-27 | 2015-01-14 | Dendron GmbH | Device for the implantation of occlusion means |
| US6878151B2 (en) | 2001-09-27 | 2005-04-12 | Scimed Life Systems, Inc. | Medical retrieval device |
| DE10155191A1 (en) | 2001-11-12 | 2003-05-22 | Dendron Gmbh | Medical implant |
| US6953473B2 (en) | 2001-12-20 | 2005-10-11 | Boston Scientific Scimed, Inc. | Detachable device with electrically responsive element |
| US6960215B2 (en) | 2002-05-08 | 2005-11-01 | Boston Scientific Scimed, Inc. | Tactical detachable anatomic containment device and therapeutic treatment system |
| US20040002732A1 (en) | 2002-06-27 | 2004-01-01 | Clifford Teoh | Stretch-resistant vaso-occlusive assembly with multiple detaching points |
| DE10233085B4 (en) | 2002-07-19 | 2014-02-20 | Dendron Gmbh | Stent with guide wire |
| US7169172B2 (en) | 2002-11-01 | 2007-01-30 | Counter Clockwise, Inc. | Method and apparatus for caged stent delivery |
| US7229454B2 (en) | 2003-01-07 | 2007-06-12 | Boston Scientific Scimed, Inc. | Occlusive cinching devices and methods of use |
| US20040193178A1 (en) | 2003-03-26 | 2004-09-30 | Cardiomind, Inc. | Multiple joint implant delivery systems for sequentially-controlled implant deployment |
| US7651513B2 (en) | 2003-04-03 | 2010-01-26 | Boston Scientific Scimed, Inc. | Flexible embolic device delivery system |
| US7569626B2 (en) | 2003-06-05 | 2009-08-04 | Dfine, Inc. | Polymer composites for biomedical applications and methods of making |
| US20070135907A1 (en) | 2003-10-02 | 2007-06-14 | The Regents Of The University Of California | Stent with expandable foam |
| US8157855B2 (en) | 2003-12-05 | 2012-04-17 | Boston Scientific Scimed, Inc. | Detachable segment stent |
| DE102004003265A1 (en) | 2004-01-21 | 2005-08-11 | Dendron Gmbh | Device for the implantation of electrically isolated occlusion coils |
| WO2005094725A1 (en) | 2004-03-31 | 2005-10-13 | Merlin Md Pte Ltd | A method for treating aneurysms |
| US8500751B2 (en) | 2004-03-31 | 2013-08-06 | Merlin Md Pte Ltd | Medical device |
| WO2005113035A2 (en) | 2004-05-21 | 2005-12-01 | Micro Therapeutics, Inc. | Metallic coils enlaced with biological or biodegradable or synthetic polymers or fibers for embolization of a body cavity |
| ATE417552T1 (en) | 2004-09-22 | 2009-01-15 | Dendron Gmbh | MEDICAL IMPLANT |
| DE502004010411D1 (en) | 2004-09-22 | 2009-12-31 | Dendron Gmbh | DEVICE FOR IMPLANTING MICROWAVES |
| AU2005304459B2 (en) | 2004-11-09 | 2011-10-13 | Stryker European Holdings I, Llc | Vaso-occlusive devices comprising complex-shape proximal portion and smaller diameter distal portion |
| US7608089B2 (en) | 2004-12-22 | 2009-10-27 | Boston Scientific Scimed, Inc. | Vaso-occlusive device having pivotable coupling |
| US20060155323A1 (en) | 2005-01-07 | 2006-07-13 | Porter Stephen C | Intra-aneurysm devices |
| ES2368857T3 (en) | 2005-02-04 | 2011-11-23 | Zuli Holdings, Ltd. | DEVICE FOR THE TREATMENT OF AN ANEURISM. |
| US20060200234A1 (en) | 2005-03-03 | 2006-09-07 | Hines Richard A | Endovascular aneurysm treatment device and delivery system |
| US20060206199A1 (en) | 2005-03-12 | 2006-09-14 | Churchwell Stacey D | Aneurysm treatment devices |
| DE102005019782A1 (en) | 2005-04-28 | 2006-11-09 | Dendron Gmbh | Device for implantation of occlusion coils with internal securing means |
| KR101237470B1 (en) | 2005-05-24 | 2013-02-26 | 가부시키가이샤 가네카 | Medical wire |
| US8002789B2 (en) | 2005-05-31 | 2011-08-23 | Stryker Corporation | Stretch-resistant vaso-occlusive devices with flexible detachment junctions |
| US8460357B2 (en) | 2005-05-31 | 2013-06-11 | J.W. Medical Systems Ltd. | In situ stent formation |
| US20060271097A1 (en) | 2005-05-31 | 2006-11-30 | Kamal Ramzipoor | Electrolytically detachable implantable devices |
| US20070073334A1 (en) | 2005-09-29 | 2007-03-29 | Kamal Ramzipoor | Combined electrolytic and mechanical separation background |
| WO2007047851A2 (en) | 2005-10-19 | 2007-04-26 | Pulsar Vascular, Inc. | Methods and systems for endovascularly clipping and repairing lumen and tissue defects |
| US20070100414A1 (en) | 2005-11-02 | 2007-05-03 | Cardiomind, Inc. | Indirect-release electrolytic implant delivery systems |
| CN101394955B (en) | 2005-11-17 | 2012-07-18 | 微排放器公司 | Three-dimensional compound coil |
| US20070186933A1 (en) * | 2006-01-17 | 2007-08-16 | Pulmonx | Systems and methods for delivering flow restrictive element to airway in lungs |
| US8998926B2 (en) | 2006-04-06 | 2015-04-07 | DePuy Synthes Products, LLC | Heat detachable coil |
| ES2564780T3 (en) | 2006-04-17 | 2016-03-29 | Covidien Lp | System to mechanically place intravascular implants |
| US8777979B2 (en) | 2006-04-17 | 2014-07-15 | Covidien Lp | System and method for mechanically positioning intravascular implants |
| WO2007134266A2 (en) | 2006-05-12 | 2007-11-22 | Electroformed Stents, Inc. | Exclusion device and system for delivery |
| EP2101682A4 (en) | 2006-12-15 | 2017-03-01 | Biosensors International Group, Ltd. | Stent systems |
| KR20100015520A (en) | 2007-03-13 | 2010-02-12 | 마이크로 테라퓨틱스 인코포레이티드 | An implant including a coil and a stretch-resistant member |
| AU2008226695B2 (en) | 2007-03-13 | 2013-05-02 | Covidien Lp | An implant, a mandrel, and a method of forming an implant |
| EP2150259A1 (en) | 2007-04-27 | 2010-02-10 | Wisconsin Alumni Research Foundation | Bioactive and biocompatible polyurethane-butanediol-glycosaminoglycan salt copolymers |
| CA2691969A1 (en) | 2007-05-18 | 2008-11-27 | Boston Scientific Scimed, Inc. | Medical implant detachment systems |
| EP2157937B1 (en) | 2007-06-04 | 2017-03-22 | Sequent Medical, Inc. | Devices for treatment of vascular defects |
| JP2011505196A (en) | 2007-12-03 | 2011-02-24 | ボストン サイエンティフィック サイムド,インコーポレイテッド | Implanting device comprising a number of thin wires and having joints that are separated by electrolysis |
| US20090227976A1 (en) | 2008-03-05 | 2009-09-10 | Calabria Marie F | Multiple biocompatible polymeric strand aneurysm embolization system and method |
| US10716573B2 (en) | 2008-05-01 | 2020-07-21 | Aneuclose | Janjua aneurysm net with a resilient neck-bridging portion for occluding a cerebral aneurysm |
| US20160206321A1 (en) | 2008-05-01 | 2016-07-21 | Aneuclose Llc | Aneurysm Occlusion Device with Sequence of Shape-Changing Embolic Members |
| US10028747B2 (en) | 2008-05-01 | 2018-07-24 | Aneuclose Llc | Coils with a series of proximally-and-distally-connected loops for occluding a cerebral aneurysm |
| CN102119040A (en) | 2008-05-02 | 2011-07-06 | 斯昆特医疗公司 | Filamentous device for treating vascular defects |
| AU2009274126A1 (en) | 2008-07-22 | 2010-01-28 | Covidien Lp | Vascular remodeling device |
| US9468739B2 (en) | 2008-08-19 | 2016-10-18 | Covidien Lp | Detachable tip microcatheter |
| EP2334242B1 (en) | 2008-09-09 | 2014-11-26 | Boston Scientific Scimed, Inc. | Composite detachment mechanisms |
| WO2010045079A1 (en) | 2008-10-13 | 2010-04-22 | Boston Scientific Scimed, Inc. | Vaso-occlusive coil delivery system |
| US8470013B2 (en) | 2008-10-20 | 2013-06-25 | Imds Corporation | Systems and methods for aneurysm treatment and vessel occlusion |
| US9211202B2 (en) | 2008-10-24 | 2015-12-15 | Wisconsin Alumni Research Foundation | Apparatus and method for treating an aneurysm |
| EP2403439B1 (en) | 2009-03-06 | 2016-07-20 | The Regents of The University of California | Thin film vascular stent and biocompatible surface treatment |
| ES2715077T3 (en) | 2009-04-06 | 2019-05-31 | Stryker Corp | Supply wire for the occlusive device supply system |
| CN102481436B (en) | 2009-04-15 | 2016-06-01 | 微排放器公司 | Implant delivery system |
| WO2010120694A1 (en) | 2009-04-16 | 2010-10-21 | Boston Scientific Scimed, Inc. | Electrical contact for occlusive device delivery system |
| US9314250B2 (en) | 2009-04-16 | 2016-04-19 | Stryker Corporation | Electrical contact for occlusive device delivery system |
| US8657870B2 (en) | 2009-06-26 | 2014-02-25 | Biosensors International Group, Ltd. | Implant delivery apparatus and methods with electrolytic release |
| EP2470257B1 (en) | 2009-08-27 | 2015-03-04 | Silver Bullet Therapeutics Inc. | Bone implants for the treatment of infection |
| WO2011053625A1 (en) | 2009-11-02 | 2011-05-05 | Boston Scientific Scimed, Inc. | Delivery wire assembly for occlusive device delivery system |
| DE102009056449A1 (en) | 2009-12-01 | 2011-06-09 | Acandis Gmbh & Co. Kg | Medical device |
| US8906057B2 (en) | 2010-01-04 | 2014-12-09 | Aneuclose Llc | Aneurysm embolization by rotational accumulation of mass |
| CN102770091B (en) | 2010-01-28 | 2015-07-08 | 泰科保健集团有限合伙公司 | Vascular remodeling device |
| DE102010021947A1 (en) | 2010-05-28 | 2011-12-01 | Phenox Gmbh | implant replacement |
| US9247942B2 (en) | 2010-06-29 | 2016-02-02 | Artventive Medical Group, Inc. | Reversible tubal contraceptive device |
| DE102010044746A1 (en) | 2010-09-08 | 2012-03-08 | Phenox Gmbh | Implant for influencing the blood flow in arteriovenous malformations |
| US9039749B2 (en) | 2010-10-01 | 2015-05-26 | Covidien Lp | Methods and apparatuses for flow restoration and implanting members in the human body |
| US9351859B2 (en) | 2010-12-06 | 2016-05-31 | Covidien Lp | Vascular remodeling device |
| KR102109781B1 (en) | 2011-01-17 | 2020-05-14 | 메타랙티브 메디컬, 인크. | Blockstent device and methods of use |
| WO2013109309A1 (en) | 2012-01-17 | 2013-07-25 | Novita Therapeutics, Llc | Expandable body device and method of use |
| US20120209310A1 (en) | 2011-02-10 | 2012-08-16 | Stryker Nv Operations Limited | Vaso-occlusive device delivery system |
| DE102011011869A1 (en) | 2011-02-22 | 2012-08-23 | Phenox Gmbh | implant |
| EP2680765A4 (en) | 2011-03-02 | 2015-11-18 | Joe Michael Eskridge | Endovascular closure system |
| US10028745B2 (en) | 2011-03-30 | 2018-07-24 | Noha, Llc | Advanced endovascular clip and method of using same |
| EP2693981A4 (en) | 2011-04-01 | 2015-07-01 | Univ Cornell | METHOD AND APPARATUS FOR RESTRICTING FLOW THROUGH OPENING IN THE LATERAL WALL OF A BODY LIGHT, AND / OR FOR STRENGTHENING WEAKNESS IN THE LATERAL WALL OF A BODY LIGHT, AND / OR FOR STRENGTHENING WEAKNESS IN THE SIDE WALL BODY LIGHT, WHILE STILL PRESENTING A SUBSTANTIALLY NORMAL FLOW THROUGH BODILY LIGHT |
| US8641777B2 (en) | 2011-06-03 | 2014-02-04 | Reverse Medical Corporation | Embolic implant and method of use |
| US20120316632A1 (en) | 2011-06-13 | 2012-12-13 | Bulang Gao | Retrievable covered stent for bifurcation aneurysms |
| US9808255B2 (en) * | 2012-03-30 | 2017-11-07 | DePuy Synthes Products, Inc. | Embolic coil detachment mechanism with flexible distal member, resistive electrical heating element and shape memory polymer element |
| EP2668914A1 (en) | 2012-06-01 | 2013-12-04 | Acandis GmbH & Co. KG | Implant system |
| US9326774B2 (en) | 2012-08-03 | 2016-05-03 | Covidien Lp | Device for implantation of medical devices |
| WO2014028913A1 (en) | 2012-08-17 | 2014-02-20 | The Regents Of The University Of California | Dual rotational stent apparatus and method for endovascular treatment of aneurysms |
| BR112015003624B1 (en) | 2012-08-22 | 2021-03-02 | Phenox Gmbh | implant with a mesh structure for occlusion of aneurysms in the region of vascular branches |
| KR101996604B1 (en) | 2012-10-31 | 2019-07-04 | 이베이스크 뉴로베스쿨러 엔터프라이즈 유엘씨 | Endovascular prosthesis and method for delivery of an endovascular prosthesis |
| US10039536B2 (en) | 2012-11-16 | 2018-08-07 | W. L. Gore & Associates, Inc. | Implantable medical device deployment system |
| JP6363691B2 (en) | 2013-03-14 | 2018-07-25 | ストライカー コーポレイションStryker Corporation | Vascular occlusive device delivery system |
| ES2879634T3 (en) | 2013-03-14 | 2021-11-22 | Stryker Corp | Vasoocclusive device delivery system |
| US10022254B2 (en) * | 2013-03-14 | 2018-07-17 | Cook Medical Technologies Llc | Polarizable delivery mechanism for medical device deployment |
| US20140316012A1 (en) | 2013-03-15 | 2014-10-23 | Toby Freyman | In-Situ Forming Foams for Embolizing or Occluding a Cavity |
| US8715314B1 (en) | 2013-03-15 | 2014-05-06 | Insera Therapeutics, Inc. | Vascular treatment measurement methods |
| US9907684B2 (en) | 2013-05-08 | 2018-03-06 | Aneuclose Llc | Method of radially-asymmetric stent expansion |
| US9480479B2 (en) | 2013-08-20 | 2016-11-01 | Stryker Corporation | Vaso-occlusive device delivery system |
| CN110013284B (en) | 2013-09-03 | 2022-04-15 | 马建录 | Detachment mechanism for implantable devices |
| CN105722474B (en) | 2013-11-13 | 2018-09-21 | 柯惠有限合伙公司 | The attachment of assist devices and thrombus in a manner of primary battery |
| GB2520482B (en) | 2013-11-15 | 2015-12-23 | Cook Medical Technologies Llc | Aneurysm closure device |
| JP5695259B1 (en) | 2014-02-19 | 2015-04-01 | 株式会社World Medish | High flexibility stent |
| US20160066921A1 (en) | 2014-02-21 | 2016-03-10 | Neuravi Limited | DEVICE AND METHOD FOR ENDOVASCULAR TREATMENT OF ANEURYSMS USING EMBOLIC ePTFE |
| US11154302B2 (en) * | 2014-03-31 | 2021-10-26 | DePuy Synthes Products, Inc. | Aneurysm occlusion device |
| JP2017515567A (en) | 2014-05-12 | 2017-06-15 | トマス,ジェフリー,イー. | Intracranial stent and embolic coil coated with photon activated gel |
| WO2015175537A1 (en) | 2014-05-16 | 2015-11-19 | Silk Road Medical, Inc. | Vessel access and closure assist system and method |
| US9814466B2 (en) * | 2014-08-08 | 2017-11-14 | Covidien Lp | Electrolytic and mechanical detachment for implant delivery systems |
| WO2016108241A1 (en) | 2014-12-31 | 2016-07-07 | Endostream Medical Ltd. | Device for restricting blood flow to aneurysms |
| JP6763864B2 (en) | 2015-01-20 | 2020-09-30 | ニューロガミ メディカル インコーポレイテッド | Micrografts and usage for the treatment of intracranial aneurysms |
| BR112017017882B1 (en) | 2015-02-25 | 2023-04-11 | Galaxy Therapeutics, Inc | Apparatus for treating an aneurysm in a blood vessel |
| WO2017074411A1 (en) | 2015-10-30 | 2017-05-04 | Blockade Medical, LLC | Devices and methods for aneurysm treatment |
| CN108472043B (en) | 2015-12-30 | 2022-05-31 | 斯瑞克公司 | Embolization device and method of making the same |
| US11051822B2 (en) | 2016-06-28 | 2021-07-06 | Covidien Lp | Implant detachment with thermal activation |
| US20180049859A1 (en) | 2016-08-16 | 2018-02-22 | Spartan Micro, Inc. | Intravascular flow diversion devices |
| CN109789008A (en) | 2016-09-14 | 2019-05-21 | 美帝诺有限公司 | Aneurysm occlusion device |
| CN108056798B (en) | 2016-11-08 | 2021-06-04 | 艾柯医疗器械(北京)有限公司 | Support pushing system, corresponding blood flow guiding device and blood flow guiding device assembling method |
| US10561441B2 (en) | 2016-12-05 | 2020-02-18 | Daniel E. Walzman | Alternative use for hydrogel intrasaccular occlusion device with an umbrella member for structural support |
| WO2018112203A1 (en) | 2016-12-14 | 2018-06-21 | eLum Technologies, Inc. | Electrospun stents, flow diverters, and occlusion devices and methods of making the same |
| WO2018129194A1 (en) | 2017-01-06 | 2018-07-12 | Incept, Llc | Thromboresistant coatings for aneurysm treatment devices |
| GB2558920A (en) | 2017-01-20 | 2018-07-25 | Cook Medical Technologies Llc | Aneurysm treatment apparatus |
| CN117297691A (en) | 2017-08-17 | 2023-12-29 | 阿里萨医疗股份有限公司 | Embolic device for use in the treatment of vascular diseases |
-
2017
- 2017-06-01 US US15/610,713 patent/US11051822B2/en active Active
- 2017-06-09 WO PCT/US2017/036690 patent/WO2018005042A1/en not_active Ceased
-
2021
- 2021-06-09 US US17/303,869 patent/US12357316B2/en active Active
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5578074A (en) * | 1994-12-22 | 1996-11-26 | Target Therapeutics, Inc. | Implant delivery method and assembly |
| US20050149108A1 (en) * | 2003-12-17 | 2005-07-07 | Microvention, Inc. | Implant delivery and detachment system and method |
| US20100121350A1 (en) * | 2007-04-12 | 2010-05-13 | Greg Mirigian | Instantaneous mechanical detachment mechanism for vaso-occlusive devices |
| US20170035437A1 (en) * | 2015-08-05 | 2017-02-09 | Henry Nita LLC | Devices and Methods for Treatment of Endovascular and Non-Endovascular Defects in Humans Using Occlusion Implants |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3603540A1 (en) * | 2018-08-03 | 2020-02-05 | DePuy Synthes Products, Inc. | Spiral delivery system for embolic braid |
| US10905431B2 (en) | 2018-08-03 | 2021-02-02 | DePuy Synthes Products, Inc. | Spiral delivery system for embolic braid |
| US11547414B2 (en) | 2018-08-03 | 2023-01-10 | DePuy Synthes Products, Inc. | Spiral delivery system for embolic braid |
| WO2021010222A1 (en) * | 2019-07-18 | 2021-01-21 | 朝日インテック株式会社 | Implant device |
| CN114126511A (en) * | 2019-07-18 | 2022-03-01 | 朝日英达科株式会社 | Implant device |
| CN112237458A (en) * | 2019-07-19 | 2021-01-19 | 柯惠有限合伙公司 | Embolic device delivery system |
| EP4003190A4 (en) * | 2019-07-19 | 2023-04-26 | Covidien LP | EMBOLIC DEVICE DELIVERY SYSTEM |
| US20230218302A1 (en) * | 2020-06-15 | 2023-07-13 | Icahn School Of Medicine At Mount Sinai | Detachment mechanism for detachable-tip endovascular devices |
| CN116211380A (en) * | 2022-07-29 | 2023-06-06 | 杭州亿科医疗科技有限公司 | Spring coil release device convenient to operate |
Also Published As
| Publication number | Publication date |
|---|---|
| US12357316B2 (en) | 2025-07-15 |
| US11051822B2 (en) | 2021-07-06 |
| US20210290246A1 (en) | 2021-09-23 |
| WO2018005042A1 (en) | 2018-01-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12357316B2 (en) | Implant detachment with thermal activation | |
| JP7534799B2 (en) | Collection System | |
| EP1608299B1 (en) | Implant delivery catheter with electrolytically erodible joints | |
| US6221066B1 (en) | Shape memory segmented detachable coil | |
| US8328860B2 (en) | Implant including a coil and a stretch-resistant member | |
| CA2481224C (en) | Devices for retaining vaso-occlussive devices within an aneurysm | |
| US20050228417A1 (en) | Devices and methods for removing a matter from a body cavity of a patient | |
| US12064119B2 (en) | Electrolytic detachment for implantable devices | |
| EP1076518A1 (en) | Method and apparatus for occlusion and reinforcement of aneurysms | |
| JP2023508444A (en) | Dissection tear closure system | |
| JP2019502513A (en) | Vascular implant system and process having a flexible withdrawal region |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AS | Assignment |
Owner name: COVIDIEN LP, MASSACHUSETTS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:DIVINO, VINCENT;RHEE, RICHARD;REEL/FRAME:042557/0079 Effective date: 20170530 |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: NOTICE OF ALLOWANCE MAILED -- APPLICATION RECEIVED IN OFFICE OF PUBLICATIONS |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: PUBLICATIONS -- ISSUE FEE PAYMENT RECEIVED |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: PUBLICATIONS -- ISSUE FEE PAYMENT VERIFIED |
|
| STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
| MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 4TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1551); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY Year of fee payment: 4 |